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ABSTRACT 
 
Aim: Leukocytes are the major source of reactive oxygen species (ROS) in the 
ejaculate and contribute to up to 30% of male infertility.  ROS have been associated 
with markers of apoptosis such as sperm DNA damage, externalization of 
phosphatidylserine and caspase-3 activation.  Therefore, this study aimed at 
investigating the impact male genital tract infections/inflammations on the induction 
of apoptosis in spermatozoa. 
Materials and Methods: Semen samples were obtained from 60 men consulting for 
fertility problems at the Reproductive Biology Unit, University of Stellenbosch at 
Tygerberg Academic Hospital, and Vincent Pallotti Hospital (Cape Town, South 
Africa).  To investigate the relationship between male genital tract infection and 
sperm apoptosis, the following were measured: semen parameters including sperm 
count, motility and forward progression; oxidative status in the ejaculate by 
evaluating the concentration of seminal leukocytes, ROS production in the ejaculate, 
generation of O2
-•
 and H2O2 by spermatozoa, and the activity of reduced glutathione 
(GSH) in sperm; sperm apoptotic markers by measuring mitochondrial membrane 
potential (Δψm), caspase-3/7 activation, and DNA fragmentation (TUNEL). 
Results: The concentration of seminal leukocytes had a significant positive 
correlation with ROS production in the ejaculate (ρ=0.378; P=0.0064), sperm O2
-•
 
production (ρ=0.336; P=0.0098), and caspase-3/7 activation in sperm (ρ=0.527; 
P<0.0001).  Furthermore, at the cutoff value of ≥0.25×106 leukocytes/mL of semen, 
the concentration of peroxidase-positive cells correlated significantly with sperm 
GSH activity (ρ=0.718; P=0.008), the percentage of sperm with disrupted Δψm 
(ρ=0.465; P=0.043), caspase-3/7 activation in sperm (ρ=0.794; P=0.001), and the 
percentage of sperm with fragmented DNA (ρ=0.563; P=0.017).  ROS production in 
the ejaculate, besides the association with seminal leukocytes, was also correlated 
with the sperm count (ρ= -0.296; P=0.033), sperm GSH activity (ρ=0.577; P<0.0001), 
caspase-3/7 activation in sperm (ρ=0.487; P=0.0005), and sperm DNA fragmentation 
(ρ=0.331; P=0.0171).  Caspase-3/7 activation was strongly correlated with oxidative 
stress in both, the ejaculate and in spermatozoa; although this parameter was not 
correlated with sperm Δψm and DNA fragmentation. Sperm O2
-•
, which had a link 
 
 
 
 
iii 
 
with seminal leukocyte concentration, was significantly correlated to sperm Δψm 
(P=0.0098), as was sperm GSH activity (P=0.0055).  Sperm DNA fragmentation was 
positively correlated with ROS in the ejaculate and sperm H2O2-production 
(P=0.039). 
Conclusions: Excessive ROS in the ejaculate, mainly a consequence of seminal 
leukocytes, is not only linked to internal generation of O2
-•
, but also to sperm DNA 
fragmentation and the activation of effector caspases.  Moreover, even in non-
leukocytospermic patients with ≥0.25×106 leukocytes/mL of semen, oxidative stress 
can occur which can trigger apoptosis, caspase-3/7 activation, and induce sperm DNA 
fragmentation.  Therefore, it is possible that male genital tract infection, the major 
cause of leukocyte infiltration in the male reproductive tract, can induce apoptosis, of 
which the observed sperm DNA fragmentation is a late feature. 
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CHAPTER ONE 
 
INTRODUCTION 
 
1.1 Background 
Infertility is defined as the failure of a couple to induce pregnancy after one year of 
regular unprotected intercourse during the fertile phase of the menstrual cycle 
(Nieschlag et al. 2000; Evers, 2002).  This inability to conceive affects up to 15% of 
all couples of reproductive age (Bruckert, 1991; Juul et al., 1999; Boivin et al., 2007) 
and in up to half of these cases the male partner is responsible for the infertility (Hull 
et al., 1985; de Kretser and Baker, 1999).  Therefore, about 7% of men may have 
impaired fertility during the course of their lives (Purvis and Christiansen, 1992; 
Nieschlag et al., 2000); a prevalence that apparently exceeds that of diabetes mellitus 
which is considered to be a common condition (Nieschlag et al., 2000; Wild et al., 
2004).  Moreover, human semen quality seems to have progressively declined over 
the past few decades (Carlsen et al., 1992; Auger et al., 1995; van Waeleghem et al., 
1996; Skakkebaek, 2006).  Considering that up to 50% of the cases of male infertility 
are classified as idiopathic (Sherins, 1995), it is clear that the aetiology of male 
infertility is poorly understood and, consequently, there are limited interventions to 
address its causes and prevent its onset.  Therefore, despite the successes of assisted 
reproductive techniques (ART) such as in vitro fertilization (IVF) and 
intracytoplasmic sperm injection (ICSI), it remains imperative to investigate the 
causes and understand the mechanisms of infertility in the human male. 
Investigations of male infertility begin with a semen analysis which provides 
descriptive information on the numbers of sperm present in the ejaculate, the 
proportion that are motile, and the percentage that are morphologically normal 
(WHO, 1999).  Many studies have clearly demonstrated that the probability of 
conception is related to sperm motility (Alper et al., 1985; Ron-el et al., 1991; 
Robinson et al., 1994), sperm concentration (Biljan et al., 1994; Calvo et al., 1994) 
and morphology (Kruger et al., 1986, 1987; Kobayashi et al., 1991; Menkveld et al., 
1996).  However, many men who demonstrate normal parameters on standard semen 
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analysis remain unable to induce pregnancy (Hull et al., 1985; WHO, 1992; Baker, 
1994).  This suggests that conventional semen analysis does not provide complete 
diagnostic information.  Furthermore, many studies show that it is not so much the 
absolute number of sperm that determines fertility, but their functional competence in 
vitro such as the ability to penetrate cervical mucus (Eggert-Kruse et al., 1989; 
Sharara et al., 1995), capacitation (Sukcharoen et al., 1995), acrosome reaction or 
sperm-oocyte fusion (Liu and Baker, 2000; 2003).  Indeed, defective sperm function 
is recognized as a major cause of the loss of fertilizing potential in infertile men  
(Hull et al., 1985; McLachlan and de Kretser, 2001).  In the proposed mechanism for 
the loss of sperm function, oxidative damage may play a key role (Alvarez et al., 
1987; Iwasaki and Gagnon, 1992, Aitken, 1994) and evidence now suggests that the 
damage to sperm, caused by oxygen-derived oxidants called reactive oxygen species, 
is a significant contributing factor in up to 30% of the cases of male infertility 
(Iwasaki and Gagnon, 1992; Ochsendorf et al., 1994; Shekarriz et al., 1995). 
Infection of the male genital tract is a known major cause of the generation of reactive 
oxygen species (ROS) in the human ejaculate (Comhaire et al., 1999; Ochsendorf, 
1999), and it has been strongly associated with sperm damage and male infertility 
(Fraczek and Kurpisz, 2007; Tremellen, 2008).  The following review discusses the 
generation of ROS in the ejaculate and their role in the pathology of human sperm, 
with particular interest in the relationship between male genital tract infection and the 
mechanisms of sperm damage. 
 
1.2 Reactive Oxygen Species 
Reactive oxygen species (ROS) are byproducts of the metabolism of oxygen by cells 
and they include free radicals and peroxides (Valko et al., 2007).  The most common 
ROS that have effects on human reproductive biology include the superoxide anion 
(O2
-•
), hydrogen peroxide (H2O2), peroxyl radicals (ROOH
•
), and the hydroxyl radical 
(OH
•
) (de Lamirande et al., 1997).  Free radicals are molecules that have one or more 
unpaired electrons in their outer orbitals.  The unpaired electrons confer a high 
oxidative potential to these ROS and a short half-life of nanoseconds, which means 
they practically react at the site of generation.  As a consequence of their high 
reactivity, free radicals readily take part in the oxidation of biomolecules such as 
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lipids, proteins, nucleic acids and hyaluronic acid, and this oxidative damage is a key 
component of pathological processes such as inflammation, carcinogenesis and ageing 
(Halliwell and Gutteridge, 1989; Sies, 1991; Fuchs et al., 1997).  The most commonly 
produced free radicals are illustrated in Table 1. 
Non-radical ROS that are either oxidizing agents or easily converted into free radicals 
include hydrogen peroxide (H2O2) and hypochlorous acid (HOCl).  Hydrogen 
peroxide is uncharged and, unlike the O2
-• 
anion and other free radicals, it can cross 
cell membranes.  Perhaps its most damaging quality is that it can be split into the very 
dangerous OH
•
 radical when it accepts an electron from ferrous or cuprous ions in a 
reaction known as Fenton reaction (Table 1) (Ochsendorf, 1999).  In addition, 
hydrogen peroxide is a major secretory product of white blood cells (Klebanoff and 
Clark, 1978), and these cells are a feature of male genital tract infection. Table 2 
describes the most common non-radical ROS; hydrogen peroxide and hypochlorous 
acid. 
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Table 1: Reactive oxygen species: most common free radicals.  
Species Generation Half-
life 
Distance
ψ
 Effect 
Hydroxyl 
radical 
(OH
•
) 
Metal ion-dependent 
breakdown of hydrogen 
peroxide. 
Fenton reaction:  
H2O2 + 1e
-
(Fe
2+
/Cu
+
)→ 
Fe
3+
/Cu
2+ 
+ OH
• 
+ OH
- 
 
Haber-Weiss reaction:  
O2
-•
+H2O2→ O2 + H2O + 
OH
•
 
0.3ns 1.8nm Very strong 
oxidant; responsible 
for initiation of 
lipid peroxidation 
and protein 
oxidation. 
Superoxide 
anion (O2
-•
) 
In mitochondria and 
endoplasmic reticulum 
during electron transport; 
first intermediate in the 
reduction of molecular O2 
by the respiratory chain. 
O2+ 1e
- → O2
-•
 
Generated through 
NADPH oxidase during 
phagocytosis.  
NADPH+2O2 → NADP
+ 
+ 
H
+ 
+ 2O2
-•
 
0.4μs-
1ms 
55nm-
3μm 
Reducing or 
oxidizing dependent 
on the redox 
properties of its 
reactant; dismutates 
to hydrogen 
peroxide. 
ψ
 distance ROS can travel. 
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Table 2: Reactive oxygen species: most common non-radical oxidants. 
Species Generation Half-
life 
Distance
ψ
 Effect 
Hydrogen 
peroxide 
(H2O2) 
Mitochondria during 
oxidative phosphorylation; 
in peroxisomes in fatty acid 
metabolism; by-product of 
SOD-catalyzed 
dismutation. 
2 O2
-• 
+ 2 H
+ → H2O2 + O2 
Persistent Very strong 
oxidant; 
responsible for 
initiation of lipid 
peroxidation and 
protein oxidation. 
Hypochlorous 
acid (HOCl) 
H2O2+ Cl
- → HOCl + OH- 
(hypochlorous acid 
formation)  
HOCl+ O2
-• → O2 +Cl
-
+ 
OH
• 
or HOCl+ Fe
2+ → 
Fe
3+
+ Cl
-
+ OH
• 
(hydroxyl 
formation) 
Activated neutrophils in 
response to infectious 
agents; reaction is catalyzed 
by peroxidase-
myeloperoxidase (MPO); 
reacts with O2
-• 
to form 
more ROS. 
Persistent Highly toxic with 
detrimental 
effects for 
neighboring cells; 
able to degrade 
biomolecules 
either directly or 
by decomposition 
into chlorine. 
ψ
 distance ROS can travel; SOD superoxide dismutase. 
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1.3 ROS production by Spermatozoa 
Spermatozoa, like all cells living under aerobic conditions, produce ROS mostly as 
products of normal metabolism.  These ROS, mostly free radicals, are produced in 
mitochondria during a stepwise reduction of oxygen to generate energy.  However, 
mitochondria are not the only source of ROS in the mammalian germ line.  Immature 
sperm are reported to generate significantly higher levels of ROS (Gil-Guzman et al., 
2001; Ollero et al., 2001; Moustafa et al., 2004).  This is because immature sperm are 
often characterized by the presence of excess cytoplasmic residues around the 
midpiece region (Aitken, 1999) and these residues are rich in the enzyme glucose-6-
phosphate dehydrogenase, an enzyme which controls the intracellular production of  
β-nicotinamide adenine dinucleotide phosphate (NADPH) through the hexose 
monophosphate shunt.  NADPH fuels the generation of ROS via the NADPH oxidase 
which is located in the plasma membrane (Gomez et al., 1996; Fisher and Aitken, 
1997). 
However, even normal human sperm are thought to have a sperm-specific and 
calcium-dependant NADPH oxidoreductase that is located in the mitochondrial 
respiration system in the sperm midpiece (Banfi et al., 2001; Armstrong et al., 2002) 
which produces ROS.  Other ROS-generating systems that have been described in 
mammalian sperm include lipoxygenase (Oliw and Sprecher, 1989) and cytochrome 
P450 (Baker et al., 2004). 
 
1.4 ROS production by Leukocytes 
Sperm are not the only source of ROS in seminal plasma.  White blood cells  
(leukocytes) are the major source of free radicals in the ejaculate and they are reported 
to produce up to 1000 times more ROS than sperm (Plante et al., 1994; de Lamirande 
and Gagnon, 1995).  Leukocytes, which are attracted by pathogens and tissue damage 
to the site of infection, release ‘bursts’ of the highly aggressive ROS as a first-line of 
defence against invading organisms (Klebanoff and Clark, 1978; Depuydt et al., 
1996).  However, even under physiological conditions, these immune cells are a 
common feature of most parts of the male reproductive tract and the ejaculate  
(Aitken et al., 1994; Aitken and Baker, 1995), of which 50-60% are 
 
 
 
 
7 
 
polymorphonuclear granulocytes, 20-30% are monocytes, and 2-5% are lymphocytes 
(Wolff and Anderson, 1988; Wolff, 1995). 
The presence of leukocytes in the ejaculate is not pathological in itself.  The mean 
number of leukocytes in the seminal fluid of healthy men has been reported to be 
17×10
6
/mL of semen (Wolff and Anderson, 1988).  According to the World Health 
Organization (WHO, 1999), a condition in which the concentration of leukocytes in 
the ejaculate is greater than 1×10
6
 cells/mL is defined as leukocytospermia.  This is 
generally considered as a clinical sign of infection or inflammation of the accessory 
sex organs, or of the lower genitourinary tract (Wolff and Anderson, 1988; Barratt et 
al., 1990).  However, this value is empirical (Aitken and Baker, 1995) and was 
regarded as too high by some authors (Menkveld and Kruger, 1998; Sharma et al., 
2001; Punab et al., 2003; Henkel et al., 2005). 
The role played by leukocytes in semen is subject to much controversy (Wolff, 1995).  
As the production of ROS is one of the principal mechanisms by which white blood 
cells destroy pathogens, it is not surprising that seminal leukocytes have been 
associated with excessive generation of ROS in the ejaculate (Aitken et al., 1994; 
Whittington et al., 1999; Sharma et al., 2001; Henkel et al., 2003a; 2005).  
Furthermore, the production of ROS by leukocytes in the ejaculate is non-specific, 
and leukocytospermia has been associated with poor sperm morphology (Menkveld 
and Kruger, 1998; Menkveld et al., 2003), increased abnormalities of the sperm 
midpiece (Thomas et al., 1997), and decreased sperm motility (Diemer et al., 2003a).  
However, some studies have found no significant negative influence of seminal 
leukocytes on semen quality or sperm function (Christiansen et al., 1991; Tomlinson 
et al., 1992; 1993; Rodin et al., 2003). 
In addition, the activation status of leukocytes appears to have an important influence 
on ROS production in the ejaculate (Tremellen, 2008).  The activation of leukocytes 
is regulated by peptides called cytokines that are produced by leukocytes and other 
cells to influence the growth, differentiation or function of cells via autocrine or 
parachrine mechanisms (Ochsendorf, 1999).  Recent data suggest that cytokines and 
ROS may interact and bring about the toxic effects of infection/inflammation in the 
male genital tract (Tremellen, 2008).  This is supported by the positive correlation 
observed between seminal ROS and pro-inflammatory cytokines such as interleukin-6 
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(Camejo et al., 2001; Nandipati et al., 2005), interleukin-8 (Rajasekaran et al., 1995; 
Martinez et al., 2007), and tumour necrosis factor (Sanocka et al., 2003; Martinez et 
al., 2007).  Interleukin-1 is reported to stimulate granulocytes and macrophages to 
produce ROS and secrete other cytokines (Depuydt et al., 1998), while interleukin-8 
is thought to exert a negative effect on sperm fertilizing potential (Rajasekaran et al., 
1995).  Interleukin-8 has also been considered to be a potential marker for male 
genital tract infection (Koumantakis et al., 1998). 
Other possible mechanisms of the development of infection-related infertility are: 
obstruction of the seminal tract (Keck et al., 1998), deterioration of spermatogenesis 
(Diemer et al., 2003b; Fraczek et al., 2007), and dysfunction of the accessory glands 
(Comhaire et al., 1999).  These mechanisms are strongly associated with 
leukocytospermia, in general, and the high production of ROS by the seminal 
leukocytes, in particular (Berger et al., 1982; Sharma et al., 2001; Henkel et al., 2005). 
The basic method of detecting leukocytes in semen samples is by direct observation 
with a bright field microscope (Menkveld and Kruger, 1998; Menkveld et al., 2003).  
However, this method is inadequate because it does not distinguish between 
leukocytes and immature germinal epithelial cells (Wolff, 1995).  Hence, other 
techniques that differentiate leukocytes from germ cells such as the Papanicolaou 
method (Menkveld and Kruger, 1998), monoclonal antibodies (WHO, 1999), and 
polymorphonuclear elastase (Henkel et al., 2007), are considered to be reliable.  
However, the peroxidase stain (Endtz test) is more suitable for routine use (Wolff, 
1998) because it is less time consuming and not labour intensive.  Furthermore, the 
peroxidase stain allows for the detection of polymorphonuclear granulocytes and its 
results are strongly correlated to ROS production in semen (Shekarriz et al., 1995). 
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1.5 Antioxidants 
The human body has developed several antioxidant strategies to protect itself from 
cellular damage induced by ROS (Sies, 1991). Antioxidants are compounds that 
scavenge, suppress the formation of ROS, and oppose their actions (Sikka et al., 
1995).  This allows for normal oxidative metabolism to occur without damage to the 
cells, while still allowing for normal ROS-mediated cellular responses such as 
destruction of infectious pathogens and intracellular signaling (Valko et al., 2007).  
Antioxidants play a significant protective role in reproductive biology and among the 
well-known enzymatic antioxidants are superoxide dismutase (SOD) and catalase 
which inactivate the O2
-•
 radical and H2O2 by converting them into water and oxygen 
(Table 3).  SOD is present within both sperm and seminal plasma (Zini et al., 1993) 
while catalase is lacking in spermatozoa (Alvarez and Storey, 1992).  The addition of 
SOD to sperm in culture has been confirmed to protect the sperm from oxidative 
attack (Kobayashi et al., 1991), and its deficiency has been reported in infertile men 
(Sanocka et al., 1997; Pasqualotto et al., 2000).  However, other authors have found 
no significant differences in SOD activity between infertile men and their fertile 
counterparts (Zini et al., 2000; Hsieh et al., 2002).  Although catalase is only found in 
seminal plasma, the reported evidence supports a link between reduced seminal 
catalase activity and male infertility (Miesel et al., 1997; Sanocka et al., 1997; Zini et 
al., 2000). 
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Table 3: Enzymatic antioxidants: superoxide dismutase and catalase. 
Enzyme Reaction 
Superoxide dismutase 
(SOD) 
2 O2
-• 
+ 2H
+   → H2O2 + O2  
Superoxide dismutase can have 3 isoforms: cytosolic 
copper/zinc superoxide dismutase (Cu/ZnSOD), intra-
mitochondrial manganese superoxide dismutase 
(MnSOD),
 
and extracellular Cu/Zn SOD.  Cytosolic 
SOD constitutes the major proportion of total SOD 
activity and probably is responsible for removing O2
-• 
radicals from the cytosol.  MnSOD is responsible for 
removing O2
-• 
generated by oxidative metabolism in 
the mitochondria. 
Catalase 2 H2O2      →   2H2O + O2  
Catalase is a hydrogen peroxide detoxifier; removes 
this membrane permeable molecule from the media 
and inhibits NADPH oxidase and thus inhibits 
superoxide production. 
 
Glutathione peroxidase (GPx) is another important enzymatic antioxidant.  This 
antioxidant is found in the testis, prostate, seminal vesicles, vas deferens, epididymis, 
seminal plasma and spermatozoa (Vernet et al., 2004).  GPx, using reduced 
glutathione (GSH; L-γ-glutamyl-L-cysteinyl-glycine) as an electron donor, protects 
sperm against ROS attack and its inhibition, in vivo, using mercaptosuccinate leads to 
a large increase in sperm lipid peroxidation (Twigg et al., 1998).  Male infertility has 
been associated with a reduction of GPx in seminal plasma (Giannattasio et al., 2002) 
and spermatozoa (Garrido et al., 2004).  Furthermore, men with excessive seminal 
ROS production that is caused by leukocytospermia, have demonstrated significantly 
reduced GPx activity within their spermatozoa (Therond et al., 1996).  Therefore, 
reduced glutathione is necessary to detoxify oxidants and free radicals in sperm, and a 
high cellular concentration of GSH is maintained by the enzyme glutathione reductase 
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which catalyzes the reduction of oxidized glutathione (GSSG) (Ochsendorf et al., 
1998), as illustrated in Figure 1. 
 
 
(From: http//:lpi.oregonstate.edu/infocenter/vitamins/riboflavin/ribogsh.jpg) 
Figure 1 One molecule of hydrogen peroxide (H2O2) is reduced to two 
molecules of water while two molecules of reduced glutathione (GSH) are oxidized in 
a reaction catalyzed by glutathione peroxidase (a selenium-dependent enzyme).  
Oxidized glutathione (GSSH) is recycled by the flavin adenine dinucleotide (FAD)-
dependent enzyme, glutathione reductase, using NADPH which itself is regenerated 
in a reaction catalyzed by glucose-6-phosphate dehydrogenase in the hexose 
monophosphate shunt.  The restored GSH is ready to detoxify more H2O2.  When the 
antioxidant system is functioning properly, most of its components are present in the 
reduced form; H2O, GSH and NADP
+
.  If there is a malfunction, then the oxidized 
components (H2O2, GSSG and NADPH) tend to accumulate. 
 
Besides the enzymatic antioxidants, small molecules that are present in semen act as 
ROS scavengers, and these include ascorbic acid (vitamin C), α-tocopherol (vitamin 
E), amino acids (taurine and hypotaurine), albumin and carnitine (Tremellen, 2008).  
These agents principally act to directly neutralize free radical activity.  A number of 
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researchers have reported a significant reduction in the activity of non-enzymatic 
antioxidants in the seminal plasma of infertile men (Fraga et al., 1991, 1996; Smith et 
al., 1996; Therond et al., 1996; Lewis et al., 1997; Mostafa et al., 2006; Song et al., 
2006). 
The antioxidant capacity of spermatozoa is insufficient by virtue of the limited 
volume and the distribution of sperm cytoplasmic space.  Therefore, antioxidants in 
the seminal plasma are essential in protecting sperm from oxidative attack.  This is 
evident in the increased ROS production in washed sperm, especially in preparation 
for assisted reproductive techniques (Plante et al., 1994; Twigg et al., 1998).  
Furthermore, repeated centrifugation separates spermatozoa from seminal plasma and 
this leads to a 20- to 50-fold increase in levels of ROS (Aitken and Clarkson, 1987; 
Iwasaki and Gagnon, 1992).  However, during spermatogenesis and epididymal 
storage, sperm are not in contact with seminal antioxidants and must rely on 
epididymal and their intrinsic antioxidant capacity.  Sperm are therefore vulnerable to 
oxidative damage during epididymal transit, especially in the presence of epididymal 
inflammation caused by male genital tract infection. 
 
1.6 Oxidative Stress and Sperm DNA Damage 
As described above, aerobic metabolism entails the production of ROS even under 
basal conditions.  Hence, there is a continuous requirement for the inactivation of 
these ROS (Sies, 1991).  However, at physiological concentrations, ROS are 
beneficial to normal sperm function, and they are associated with sperm capacitation 
and hyperactivation (de Lamirande and Gagnon, 1993; Aitken and Fisher, 1994; de 
Lamirande et al., 1997), thereby assisting sperm in their transit through the cumulus 
and zona pellucida.  It is obvious, then, that in the male reproductive system, a 
balance has to be maintained between the generation of ROS and their scavenging by 
the battery of antioxidants in the seminal plasma and in the sperm (Alvarez et al., 
1987; Halliwell and Gutteridge, 1989; Sikka et al., 1995).  However, increased ROS 
production or deficient antioxidant protection causes this balance to shift in favour of 
oxidants, potentially leading to cellular or genetic damage - this condition is called 
‘oxidative stress’. 
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The underlying mechanism of sperm damage, which is induced by oxidative stress, is 
peroxidation of the sperm plasma membrane (Jones et al., 1979).  The plasma 
membrane of human sperm is particularly vulnerable to ROS attack because it has an 
exceptionally high content of polyunsaturated fatty acids (Alvarez et al., 1987; Zalata 
et al., 1998).  The ROS-induced peroxidation reduces sperm membrane fluidity and 
tail motion and, therefore, less sperm reach the oocyte for fertilization (Whittington et 
al., 1999; Kao et al., 2008).  Moreover, ROS not only damage the sperm membrane, 
but are also known to attack the sperm genome (Twigg et al., 1998). 
Several investigators have directly linked ROS production to sperm nuclear DNA 
damage (Kodama et al., 1997; Lopes et al., 1998; Saleh et al., 2002a; Wang et al., 
2003; Henkel et al., 2005).  Normally, sperm DNA is tightly packaged by protamines 
and this protects its purine and pyrimidine bases and the deoxyribose backbone from 
free radical attack (Ward and Coffey, 1991).  However, this protamination is deficient 
in some infertile men (Balhorn et al., 1988; Aoki and Carrell, 2003; Oliva, 2006), and 
their sperm DNA is exposed to ROS-induced oxidation.  Furthermore, DNA damage 
is significantly greater in leukocytospermic semen samples (Alvarez et al., 2002; 
Henkel et al., 2003a; 2003b) and in infertile men who may have reduced antioxidant 
protection (Pasqualotto et al., 2000). 
The negative impact of sperm DNA fragmentation on fertilization and pregnancy has 
been repeatedly and clearly demonstrated (Figure 2).  Sperm DNA damage was 
associated with poor motility and abnormal morphology (Huang et al., 2005; Sergerie 
et al., 2005), and reduced acrosome reaction (Ozmen et al., 2007).  Furthermore, high 
incidence of sperm DNA fragmentation has been observed among couples with 
unexplained infertility and recurrent pregnancy failure (Host et al., 2000; Carrell et 
al., 2003).  This negative influence of sperm nuclear DNA damage has been 
demonstrated for intrauterine insemination (IUI) (Duran et al., 2002) and in vitro 
fertilization (IVF) (Henkel et al., 2004).  Even in natural conception, oxidative sperm 
DNA damage adversely affects human fertility and prolongs the time to pregnancy 
(Spanò et al., 2000; Loft et al., 2003).  Despite this, there is evidence to suggest that 
sperm with fragmented DNA are still able to fertilize an oocyte but further 
development stops once the defective paternal genome is switched on, resulting in 
failed pregnancy (Twigg et al., 1998; Ahmadi and Ng, 1999; Henkel et al., 2004).  
Fragmented DNA appears to cause of poor embryo quality, poor blastocyst 
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development and even early embryo death (Tomsu et al., 2002; Zorn et al., 2003; Seli 
et al., 2004; Meseguer et al., 2008).  Assisted reproductive techniques, such as 
intracytoplasmic sperm injection (ICSI), circumvent natural barriers to fertilization 
and allow sperm with damaged DNA to achieve blastocyst formation and even full-
term pregnancy (Gandini et al., 2004).  However, there is rising concern that the 
genetic damage may be transmitted to the offspring, causing chromosomal 
abnormalities, birth defects, childhood cancer (Aitken and Krausz, 2001; Aitken and 
De Iuliis, 2007), and even infertility (Silber and Repping, 2002). 
 
 
Figure 2 An assortment of factors can conspire to induce oxidative stress and 
nuclear DNA damage in spermatozoa emerging from the male reproductive tract.  
Studies have demonstrated the consequences of damage to the male genome, and 
these include infertility, poor blastocyst formation and embryo development, and 
increased abortion.  Moreover, there is rising concern that genetic damage may be 
transmitted to the offspring and may cause childhood disease such as cancer. 
(Adapted from Aitken and Krausz, 2001). 
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Several investigators have confirmed the damaging effect of oxidative stress on the 
sperm genome (Kodama et al., 1997; Aitken et al., 1998; Saleh et al., 2002a; Wang et 
al., 2003; Moustafa et al., 2004; Henkel et al., 2005).  Furthermore, studies show that 
sperm DNA damage is predictive of fertilization and pregnancy after natural 
conception and following the use of assisted reproduction such as IUI (Duran et al., 
2002), IVF (Host et al., 2000; Henkel et al., 2004), and ICSI (Lopes et al., 1998; 
Henkel et al., 2003b; Tesarik et al., 2004).  For these reasons, various authors have 
suggested that tests for DNA integrity or damage should be introduced into the 
routine andrological work-up (De Jonge, 2002; Perreault et al., 2003; Sharma et al., 
2004; Tesarik et al., 2004; Henkel et al., 2005).  A number of tests have been 
developed to assess sperm DNA damage, and these include sperm chromatin structure 
assay (SCSA), terminal deoxynucleotide transferase-mediated dUTP nick-end 
labelling (TUNEL) assay, and measurement of 8-hydroxydeoxyguanosine (8-OHdG).  
The TUNEL assay is highly specific and easily reproducible and, therefore, is one of 
the most frequently used to test to investigate sperm DNA fragmentation (Henkel, 
2007). 
 
1.7 Male Genital Tract Infection and Oxidative Stress 
The causes of oxidative stress are manifold (Figure 2).  They include smoking (Fraga 
et al., 1996), excessive alcohol consumption (Maneesh et al., 2006), environmental 
pollution (Chitra et al., 2001); chronic systemic disease (Oberg et al., 2004; Agbaje et 
al., 2007), and infection (Mazzilli et al., 1994; Depuydt et al., 1996; Ochsendorf, 
1999; Potts et al., 2000; Brackett et al., 2008).  Among the latter, male genital tract 
and accessory gland infections play a significant, and yet potentially correctable, role 
in male infertility (Cunningham and Beagley, 2008; Pellati et al., 2008; Schuppe et 
al., 2008; Tremellen, 2008).  The prevalence of infertility that is related to male 
genital tract infection varies from 10% to 20% in randomly selected subjects (WHO, 
1999), and up to 35% in a study of over 4000 patients consulting for infertility 
(Henkel et al., 2007).  Reportedly, up to 50% of men suffer from prostatitis at some 
point in their lives, with the condition becoming chronic in 10% of men (Schaeffer, 
2003).  The majority of these infections are self-limiting (Weidner et al., 1999), and 
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the men do no present with clear symptoms of genital tract infection (Gonzales et al., 
2004), so most these men will not seek treatment. 
In male genital tract infection, activated leukocytes generate excessive ROS and 
secrete cytokines that have been negatively correlated with fertility (Depuydt et al., 
1998) and semen quality (Eggert-Krause et al., 2001).  The highly oxidant ROS 
cocktail released by leukocytes, such as OH
•
, O2
-•
 and the persistent H2O2, can induce 
lipid peroxidation (Zalata et al., 1998) and substantial sperm DNA fragmentation 
(Alvarez et al, 2002), especially in infertile patients with deficient antioxidant 
capacity (Pasqualotto et al., 2000).  It is also worth considering that, in cases of 
longstanding male genital tract infection and inflammation such as orchitis, 
epididymitis (Weidner et al., 1999), and even prostatitis (Henkel et al., 2006), 
spermatozoa are exposed to activated leukocytes and their products for long periods 
during their maturation.  Therefore, causality between leukocytes in the ejaculate and 
DNA fragmentation in spermatozoa should not be underestimated (Figure 3). 
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Figure 3 Overview of some of the harmful effects of male genital tract infection 
on leukocytes in the ejaculate, cytokines, and sperm function.  Interleukin-1 (IL-1) is 
reported to stimulate seminal leukocytes, among which activated polymorphonuclear 
(PMN) leukocytes and macrophages (M) release reactive oxygen species (ROS) into 
the seminal plasma.  These ROS, such as hydrogen peroxide and superoxide anion, 
cause lipid peroxidation and sperm DNA damage which contribute to infertility.  
Interleukin-8 (IL-8) is also reported to have a negative effect on sperm fertilizing 
potential.  Lymphocytes (B) have not been directly associated with male infertility. 
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1.8 Apoptosis 
Apoptosis is a mode of cell death that involves a series of genetically-regulated 
morphological and biochemical alterations leading the cell to controlled death (Kerr et 
al., 1972).  In the male reproductive tract, it seems clear that this programmed cell 
death is a key phenomenon during spermatogenesis (Gorczyca et al., 1993; Sun et al., 
1997; Lopes et al., 1998; Sakkas et al., 1999; Barroso et al., 2000; Irvine et al., 2000).  
Recently, several features that are characteristic of apoptosis in somatic cells have 
been described in human spermatozoa.  Ejaculated sperm, particularly from infertile 
men, have been reported to show Fas expression (Sakkas et al., 2002; Taylor et al., 
2004), translocation of phosphatidylserine (Henkel et al., 2004), and reduction in 
mitochondrial membrane potential (MMP; Δψm) (Paasch et al., 2004).  Caspases 
(aspartic acid-directed cysteine proteases) are also intimately involved in apoptosis 
and they have been described in human spermatozoa (Wang et al., 2003).  To date, 14 
caspases have been identified in humans, and they have been divided into two 
functional subgroups; initiating caspases (caspase-6, -8, -9, and -10), and effector 
caspases (caspase-2, -3, and -7) (Nicholson, 1999).  Caspases, initially inactive, are 
activated by a cascade of apoptotic events which, ultimately, converge on caspase-3; 
the executioner. This caspase then irreversibly activates specific enzymes that degrade 
the nuclear DNA (Earnshaw et al., 1999).  In sperm, as in somatic cells, DNA 
fragmentation is regarded as a late feature and a hallmark of apoptosis, and it is often 
preceded by early markers of programmed cell death, such as caspase activation, Fas 
expression or Δψm disruption (Oosterhuis et al., 2000). 
Although a number of pathways for the activation of the apoptotic cascade have been 
cited, the evidence strongly supports two: the death receptor (extrinsic) pathway, and 
the mitochondrial (intrinsic) pathway (Reed, 2000; Green, 2003).  In the extrinsic 
pathway, death receptors of the tumour necrosis factor family, including Fas, transmit 
signals via the Fas-associated death domain (FADD) and this triggers caspase-8 
which in turn activates caspase-3 (Nagata, 2000).  In the intrinsic pathway, on the 
other hand, apoptosis is induced by signals which include a variety of proteins (Bak, 
Bax or BH1) that activate the mitochondria to release cytochrome c (Liu et al., 1996).  
ROS can also trigger apoptosis via the intrinsic pathway by destabilizing the 
mitochondrial membrane and disrupting the electron transfer chain (Green and Reed, 
1998).  Cytocrome c enters the cytosol and cleaves caspase-9 which in turn activates 
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caspase-3.  Friedlander (2003) demonstrated a significant positive correlation of 
endogenous generation of ROS with oxidative stress-induced sperm damage.  They 
proposed that the exposure of mitochondria to ROS leads to the release of an 
apoptosis-inducing factor (AIF), which directly interacts with DNA and leads to DNA 
fragmentation (Cande et al., 2002; Friedlander, 2003).  In addition, positive 
correlation was reported to exist between increased ROS in the ejaculate and high 
levels of cytochrome c, caspase-3 and -9 (Wang et al., 2003).  Therefore, it is 
conceivable that exogenous ROS, such as from activated seminal leukocytes in the 
presence of male genital tract infection, can induce mitochondrial damage which can 
lead to sperm DNA fragmentation and apoptosis via the mitochondrial apoptotic 
pathway (Figure 4). 
  
 
 
 
 
20 
 
 
Figure 4 Proposed apoptotic signaling pathways in ejaculated spermatozoa of 
infertile men.  Apoptotic signaling pathways in sperm are extrapolated from current 
knowledge of apoptosis in somatic cells. (* indicates apoptosis-related markers found 
in spermatozoa of infertile men). Δψm = mitochondrial membrane potential;  
ROS = reactive oxygen species; Fas = fibroblast-associated death receptor;  
PS = phosphatidylserine. (Figure adapted from Marchetti and Marchetti, 2007). 
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1.9 Aim of the Study 
From the literature, it is clear that ROS play an important role in the normal 
physiology and pathology of the male germ cell.  Furthermore, the human sperm is 
particularly susceptible to oxidative attack, not only for the high lipid content of its 
plasma membrane, but also because of their inadequate intrinsic antioxidant store.  
This vulnerability of sperm becomes important when the more robust seminal 
antioxidant system either malfunctions, or is overwhelmed by excessive ROS 
generation; as may be the case in the presence of activated seminal leukocytes.  
Considering that oxidative stress has been strongly and repeatedly linked to DNA 
fragmentation; a late event of apoptosis, it is possible that male genital tract infection 
and the attendant infiltration of activated leukocytes into the reproductive tract and the 
ejaculate, may induce apoptosis in human sperm. 
The aim of this study is to investigate the relationship between: 
1. male genital tract infection as indicated by the presence of leukocytes in the 
ejaculate; 
2. the oxidative status in sperm and the ejaculate by evaluating the generation of 
ROS by sperm and in the ejaculate, and assessing the antioxidant activity in 
sperm by measuring the concentration of reduced glutathione; 
3. and the markers of sperm apoptosis: Δψm disruption and caspase-3/7 
activation in sperm as early markers of apoptosis, and sperm nuclear DNA 
fragmentation as a late apoptotic event. 
 
 
 
 
22 
 
CHAPTER TWO 
 
MATERIALS AND METHODS 
 
Figure 5 illustrates the experimental set-up of the study. 
SEMEN SAMPLE
ANTIOXIDANT 
EVALUATION 
SPERM GSH 
CONCENTRATION
EVALUATION OF 
ROS
SEMINAL 
LEUKOCYTE 
EVALUATION
DNA 
FRAGMENTATION
STANDARD SEMEN 
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ROS PRODUCTION 
IN SPERM 
FLUORESCENCE
ROS PRODUCTION 
IN THE 
EJACULATE 
LUMINESCENCE
MITOCHONDRIAL 
MEMBRANE 
POTENTIAL
CASPASE-3/7 
ACTIVATION
GSH-GLO 
LUMINESCENCE 
ASSAY
PEROXIDASE 
REACTION 
(ENDTZ TEST)
TUNEL ASSAY
H2DCFDA
DHE
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LUMINOL DEPSIPHER
CASPASE-GLO 
LUMINESCENCE 
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SPERM 
APOPTOTIC 
MARKERS
 
Figure 5 The study had three experimental sub-groups: a standard semen 
analysis; evaluation of oxidative status, in spermatozoa and in the ejaculate; and 
assessment of sperm apoptotic markers.  ROS = reactive oxygen species;  
GSH = reduced glutathione; DHE = dihydroethidium;  
H2DCFDA = 2,7-dichlorofluorescein diacetate. 
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2.1 Sample Collection 
Semen samples were obtained from 60 men who attended the Reproductive Biology 
Unit in the Department of Obstetrics and Gynaecology, University of Stellenbosch at 
the Tygerberg Academic Hospital, Tygerberg, South Africa; and Vincent Pallotti 
Hospital, Pinelands, South Africa, for fertility problems or assisted reproduction 
treatment.  The samples were collected by masturbation into sterile plastic cups 
following 2-4 days of sexual abstinence.  This study was approved by the Research 
Committee at the Faculty of Science, University of the Western Cape, and ethical 
clearance was obtained by the relevant Institutional Review Boards. 
 
2.2 Conventional Sperm Parameters 
Semen analysis was performed by experienced scientists to determine the sperm 
concentration, the percentage of motile sperm, and the sperm forward progression 
according to the World Health Organization criteria (WHO, 1999).  For the sperm 
forward progression, a grading system on a scale of 1-4 was used  
(Hotchkiss et al., 1938) which was then assigned arbitrary values to allow for 
statistical analysis (Table 4). 
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Table 4: Forward progression grading system. 
Hotchkiss 
Scale 
Arbitrary 
grading 
Description of movement 
0 0 No movement 
1 1 Movement – no forward 
1+ 1.33 Movement – forward now and then 
2 2 Movement – slow and undirected 
2+ 2.33 Movement – slow but directed forward 
3- 2.66 Movement – fast but undirected 
3 3 Movement – fast and directed forward 
3+ 3.33 Movement – very fast and directed forward 
4 4 Movement – extremely fast and directed forward 
 
 
2.3 Oxidative Status in the Ejaculate and in Sperm 
2.3.1 Concentration of Peroxidase-positive Leukocytes 
The concentration of leukocytes in the ejaculate was determined using the peroxidase 
stain (Shekarriz et al., 1995).  A benzidine stock was prepared by dissolving 125 mg 
of benzidine (4,4-diaminobiphenyl; Sigma Chemical Co., St Louis, MO, USA ) in a 
mixture of 50 mL of distilled water, and 50 mL of 96% ethanol (Merck, 
Johannesburg, South Africa) at room temperature (RT).  This solution was prepared in 
4 mL aliquots and stored away from light at 4°C.  To prepare a working solution, 5 
µL of 30% hydrogen peroxide (Chemical and Laboratory Suppliers, Cape Town, 
South Africa) was added to the 4 mL aliquots of the stock solution.  In the staining 
procedure, 20 µL of liquefied semen were mixed with 20 µL of the benzidine working  
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solution in a 1.5 mL reaction tube (Greiner Bio-One GmbH, Frickenhausen, 
Germany), and allowed to stand for 5 minutes at RT.  Peroxidase-positive leukocytes 
stained brown (Figure 6) and these were counted in a Makler Chamber (Sefi-Medical 
Instruments, Haifa, Israel) using a light microscope at ×400 magnification.  The 
results were corrected for dilution and recorded as the number of peroxidase-positive 
cells (×10
6
)/mL of semen.  Ejaculates with leukocyte counts of greater than 1×10
6
/mL 
were classified as leukocytospermic in accordance with the WHO (1999). 
 
 
Figure 6 A seminal leukocyte after the peroxidase stain. (×1000 magnification) 
 
2.3.2 Measurement of ROS production in the Ejaculate 
The generation of ROS in the ejaculate was measured by using a chemiluminescence 
assay with 4 mmol/L luminol (5-amino-2,3 dihydro-1,4 phalazinedione; Sigma) as 
described by Shekarriz et al. (1995).  Luminol is a sensitive chemiluminescence probe 
that reacts with a variety of ROS including hydrogen peroxide, hydroxyl radicals and 
the superoxide anion (Aitken and West, 1990).  A Berthold luminometer 
(MicroLumat Plus LB 96 V, Bad-Wildbad, Germany) was used to inject the luminol 
and to read the luminescence.  Liquefied semen was diluted 1:5 in human tubal fluid 
(Quinn et al., 1985) medium supplemented with 10 mg/mL human serum albumin 
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(HTF-HSA), and then centrifuged for 10 minutes at 300×g at RT.  After discarding 
the supernatant, the resultant pellet was re-suspended in 750 µL of HTF-HSA medium 
and then 250 µL of suspension were transferred to 2 wells of a white microtitre plate 
(Dynatech MicroFLUOR™, Chantilly, VA, USA).  The first well in each row was 
designated a negative control and contained 250 µL of HTF-HSA medium only.  The 
luminometer was set in the integrated mode to inject 25 µL of luminol into each well 
and read the luminescence for 10 minutes.  Background luminescence which was 
obtained from the negative control reading was subtracted from all test values.  The 
concentration of ROS was expressed as relative light units (×10
4
 RLU) per 20×10
6
 
sperm.  All readings were performed in duplicate. 
 
2.3.3 Measurement of Hydrogen Peroxide 
Hydrogen peroxide (H2O2) is cell permeable and plays an important role in sperm 
mitochondrial membrane potential disruption and induction of DNA strand breaks.  
However, the methods of measuring this highly reactive oxidant are controversial.  
For this reason, 2 fluorescent probes were used to measure intracellular production of 
H2O2 by sperm. 
 
2.3.3.1 2,7-Dihydrofluorescein diacetate. 
2,7-dihydrofluorescein diacetate (H2DCFDA, Molecular Probes, Eugene, Oregon, 
USA) was reconstituted to 50 µM in PBS and stored in 100 µL aliquots at -80°C 
protected from light.  H2DCFDA is a stable, non-fluorescent cell-permeable probe 
which de-esterifies in the presence of intracellular H2O2 to form a fluorescent  
2,7-dichlorofluorescein (DCF). 
Semen samples were washed in PBS and centrifuged at 300×g for 10 minutes.  After 
centrifugation, the supernatant was discarded and the pellet was re-suspended in PBS.  
Following this, 20 µL of H2DCFDA was added to 400 µL of the washed semen (final 
concentration of H2DCFDA is 2.5 µM) and incubated for 45 minutes at 37°C 
protected from light.  The mixture was then centrifuged again for 10 minutes at 300×g 
and the pellet was re-suspended in 400 µL of PBS.  A fluorescence microscope 
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(Zeiss), fitted with a 488 nm excitation filter and 510-530 nm emission filter, was 
used to analyze the sperm at ×400 magnification.  All sperm fluorescing bright green 
(Figure 7) were H2O2-positive and expressed as a percentage of the total sperm 
observed in that field [H2O2-positive (DCF) (%)]. 
 
 
Figure 7 A sperm with a head deformity (arrow, A) was H2O2-positive and 
fluoresced bright green (arrow, B) after staining with H2DCFDA. (×1000 
magnification) 
 
2.3.3.2 Amplex UltraRed™ and Horseradish Peroxidase (HRP) 
A working solution of 100 µM Amplex UltraRed™ reagent (10-acetyl-3,7-
dihydrophenoxazine, Molecular Probes), and 0.2U/mL HRP (Sigma) was prepared by 
mixing 50 µL of 10 mM Amplex UltraRed™ reagent stock solution, 100 µL of 10 
U/mL HRP and 4.85 mL of 1X reaction buffer (50 mM sodium phosphate, Merck).  
This 5 mL volume was stored in 50 µL aliquots at -80°C protected from light.  For 
each semen sample, 100 µL ejaculate was washed in PBS and centrifuged for  
10 minutes at 300×g, the resultant supernatant was discarded and the pellet was re-
suspended in PBS.  Thereafter, 50 µL of the washed semen was mixed with 50 µL of 
Amplex UltraRed™ working solution, and incubated for 30 minutes at RT away from 
light.  The Amplex UltraRed™ reagent reacted with H2O2 to produce a red 
fluorescence oxidation product called resofurin.  Therefore, the sperm fluorescing red 
B A 
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(Figure 8) when analyzed at ×400 magnification with a fluorescence microscope 
(Zeiss) equipped with 488 nm excitation and 590 emission filters were considered to 
be H2O2-positive and recorded as a percentage of the total number of sperm under 
observation [H2O2-positive (Amplex) (%)]. 
 
 
Figure 8 H2O2-positive sperm (white arrows) showed a red fluorescence (B) 
after staining with Amplex UltraRed™ and HRP.  The arrow head (A) shows a H2O2-
negative sperm which showed no fluorescence (B).  The polymorphonuclear 
leukocyte (L) also stained positive for H2O2.  The pictures were difficult to take 
because the fluorescence faded quickly after exposure to UV light. (×1000 
magnification) 
 
2.3.4 Measurement of Superoxide Anion (O2
-•
) 
Intracellular generation of O2
-•
 was estimated using dihydroethidium (DHE, 
Molecular Probes), an uncharged probe that reports overall cellular O2
-•
 production.  
When DHE is oxidized by O2
-•
 within the cell, it produces DNA sensitive 
fluorochromes that generate a orange/red nuclear fluorescence when excited at  
488 nm (Rothe and Valet, 1990).  For this assay, a 20 µM DHE stock solution was 
prepared by dissolving 6.3 mg of DHE in 1 mL of DMSO (Sigma) and then adding 
999 mL of distilled water.  A 100 µL volume of ejaculate was diluted (1:2) with PBS 
and then centrifuged at 300g for 10 minutes.  After discarding the supernatant, the 
L L 
B A 
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pellet was re-suspended with PBS.  Following this, 20 µL of DHE stock was added to 
180 µL of sperm suspension, and then incubated for 15 minutes at 37°C in the dark.  
After incubation, a wet smear was made on a slide and then analyzed under a 
fluorescence microscope (Zeiss) at ×400 magnification.  The excitation wavelength 
was 488 nm and the emission filter was 590 nm.  Orange/red fluorescing sperm [O2
-•
-
positive sperm (DHE) (%); Figure 9] were recorded as a percentage of all the sperm 
observed. 
 
 
Figure 9 Spermatozoa after staining with DHE; O2
-•
-positive sperm (arrows) 
fluoresced orange/red, and O2
-•
-negative sperm (arrow heads).  (×1000 magnification) 
 
2.3.5 Measurement of Reduced Glutathione (GSH) activity in Sperm 
The GSH-Glo™ luminescence assay (Promega) was used to estimate the activity of 
reduced glutathione (GSH) in the ejaculate.  GSH, a substrate of glutathione 
peroxidase, is part of an antioxidant enzymatic scavenging system that forms an 
important intracellular defence against oxidative stress.  The GSH-Glo™ assay is 
A B 
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based on the conversion of a luciferin derivative in the presence of GSH which is 
catalyzed glutathione S-transferase (GST).  The signal generated in the reaction is 
proportional to the amount of GSH present in the sample. 
For the assay, a GSH-Glo™ reagent 2X was prepared according to manufacturer’s 
instructions.  In brief, 50 µL GSH-Glo™ reagent 2X contains 0.5µL Luciferin-NT 
substrate, 0.5 µL GST, and 49 µL of reaction buffer.  A reconstituted Luciferin 
detection reagent stock solution was also prepared by adding Luciferin detection 
reagent to Luciferin reaction buffer as per manufacturer’s instructions.  The 50 µL 
GSH-Glo™ reagent 2X was added to 50 µL of washed semen (diluted with PBS, 
centrifuged for 10 minutes at 300×g, and re-suspended with PBS) and then incubated 
for 30 minutes at RT protected from light in a 1.5 mL reaction tube.  Subsequently,  
50 µL reconstituted Luciferin detection reagent was added and the reaction mixture 
was incubated for 15 minutes at RT away from light.  Following this, 100 µL of the 
reaction mixture was transferred to a microtitre plate (Dynatech MicroFLUOR™).  
Luminescence was measured using a Berthold luminometer (MicroLumat Plus  
LB 96 P) set at integration mode to measure luminescence for 30 seconds for each 
well.  The first well in each row contained a negative control which was prepared and 
incubated in the same way as the test, but with 50 µL PBS replacing 50 µL washed 
semen.  The negative control luminescence was subtracted from the test result and the 
outcome was recorded as ×10
4
 RLU/20×10
6
 sperm. 
 
2.4 Sperm Apoptotic Markers 
2.4.1 Determination of the Integrity of MMP (Δψm) 
The membrane potential of the mitochondria (Δψm) in sperm was determined using a 
lipophilic cationic dye DePsipher™ (Trevigen, Minneapolis, USA).  Each aliquot of 
DePsipher™ contained 1 µg of the dye diluted in 1 mL of PBS.  After washing with 
PBS, a sample was centrifuged for 10 minutes at 300×g.  The pellet was then re-
suspended with 50-200 µL of DePsipher™ and incubated at 37°C in 5% CO2 for 20 
minutes protected from light.  After incubation, the sample was centrifuged and the 
pellet was re-suspended with a reaction buffer.  The sample was immediately 
observed using a fluorescence microscope with a 488 nm excitation filter (Zeiss) at 
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×400 magnification.  Sperm with intact Δψm excited an intense red fluorescence  
(590 nm emission filter) due to the formation of dye aggregates inside mitochondria 
(Figure 10, A).  In the sperm with disrupted Δψm (Δψm-negative sperm), the monomer 
dye fluoresced green (530 nm emission filter) (Figure 10, B).  The number of Δψm-
negative sperm was recorded as a percentage of the total number of sperm counted. 
 
 
Figure 10 After staining with DePsipher™, sperm with intact Δψm showed red 
fluorescence (A), while those with disrupted Δψm had a green fluorescence (white 
arrow; B).  (×1000 magnification) 
 
2.4.2 Measurement of Caspase-3/7 activation in Sperm 
Caspase activation was determined using the Caspase-Glo™3/7 assay (Promega).  
This luminescent assay measures the activities of caspase-3 and -7 which are 
members of the cysteine aspartic acid-specific protease (caspase) family that play key 
effector roles in apoptosis in mammalian cells. 
The Caspase-Glo™ reagent was prepared by mixing the Caspase-Glo™ substrate and 
Caspase-Glo™ buffer at RT protected from light.  The resultant reagent was then 
stored in 100 µL aliquots and at -80°C.  Semen samples were washed in PBS and 
centrifuged at 300×g for 10 minutes.  Following this, the supernatant was discarded 
and the pellet was re-suspended in PBS.  A 100 µL aliquot of Caspase-Glo™ reagent 
A B 
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was then equilibrated to RT and mixed with 100 µL of the washed semen sample in a 
reaction tube.  The mixture was then incubated for 60 minutes away from light at RT.  
After incubation, the contents of the reaction tube were homogenized, and then  
100 µL of the reaction mixture were transferred into a white microtitre plate 
(Dynatech MicroFLUOR™) as the test.  The first well of each row was used as a 
negative control and it contained 100 µL of PBS mixed with 100 µL of Caspase-
Glo™ reagent which had been incubated for 60 minutes.  Luminescence was 
measured using a Berthold luminometer (MicroLumat Plus LB 96 P) set at integration 
mode to measure luminescence for 30 seconds for each well.  The Caspase-Glo™ 
reagent contains the tetrapeptide sequence DEVD which causes cell lysis followed by 
caspase cleavage resulting in a luminescent signal that is proportional to the caspase 
activity present in the reaction.  The negative control luminescence was subtracted 
from the test result and the outcome was recorded as ×10
4
 RLU/20×10
6
 sperm. 
 
2.4.3 Measurement of Sperm DNA Fragmentation 
DNA fragmentation was measured by using the terminal deoxynucleotidyl 
transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay (Henkel et al., 
2003b).  The TUNEL assay quantifies the incorporation of deoxyuridine triphosphate 
(dUTP) at single and double strand DNA breaks in an enzymatic reaction by labeling 
the free 3’-OH and the modified nucleotides with terminal deoxynucleotidyl 
transferase. 
After washing samples in phosphate buffered saline (PBS) (Oxoid Ltd., Hampshire, 
England), the resultant pellet was re-suspended, and a wet smear was made on a 
StarFrost™ slide (Knittel Gläser, Braunschweig, Germany) and left to air-dry at RT.  
The slides were then fixed in 4% formaldehyde in PBS (pH 7.4) for 25 minutes at 
4°C.  After fixation, the slides were washed in PBS for 5 minutes at RT and 
permeabilized in 0.2% Triton™ X-100 (Sigma) in PBS for 5 minutes at RT.  The 
slides were then rinsed twice in PBS for 5 minutes at RT.  A 100 µL of equilibration 
buffer was added to each slide and allowed to equilibrate for 10 minutes.  After this, 
20 µL of TUNEL reagent (DeadEnd™, Promega, Madison, WI, USA) was added to 
each slide and then a plastic cover slip (Promega) was applied.  Following incubation 
for 60 minutes at 37°C in a humidified chamber away from light, the reaction was 
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terminated by immersion in 2×SSC (Promega) for 15 minutes.  The slides were then 
washed in PBS three times and more than 200 randomly selected sperm were 
immediately analyzed using a fluorescence microscope (Zeiss, Oberkochen, 
Germany) equipped with a 50W mercury lamp, a 488 nm excitation filter and a  
510-530 nm emission filter, at ×400 magnification with an oil immersion objective.  
Sperm with normal DNA only had background staining (TUNEL-negative), while 
those with fragmented DNA had a bright green fluorescence (TUNEL-positive) 
(Figure 11).  TUNEL-positive sperm were recorded as a percentage of the total 
number of sperm per field. 
 
 
Figure 11 Sperm with nuclear DNA damage (TUNEL-positive sperm) fluoresced 
bright green (white arrows) after TUNEL assay.  TUNEL-negative sperm (white 
arrow heads) showed background staining only.  (×1000 magnification) 
 
2.5 Statistical Analysis 
Normal distribution was tested by means of the D’Agostino-Pearson test (D’Agostino 
and Pearson, 1973), and following this parametric and nonparametric tests were 
performed accordingly.  The results were presented as mean±SD, median and range.  
A P-value of less than 0.05 (P < 0.05) was considered for statistical significance.  In 
order to compare the Amplex UltraRed™ and H2DCFDA assays which were used to 
determine H2O2 generation is sperm, Bland and Altman (Bland and Altman, 1986), 
and Mountain plots (Krouwer and Monti, 1995) were performed as well as 
B A 
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concordance correlation coefficients (Lin, 1989) were calculated.  The latter evaluates 
the degree to which pairs of observations fall on a 45º line through the origin, and it 
contains a measure of precision (Pearson correlation coefficient: ρ) and accuracy 
(Bias correlation factor: Cb).  
MedCalc® statistical software (version 9.3.8.0; Mariakerke, Belgium) was used to 
perform all statistical tests and analyses. 
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CHAPTER THREE 
 
RESULTS 
 
3.1 Summary Statistics 
The summary statistics of the parameters that were analyzed in this study are shown 
in Table 5.  Following the D’Agostino-Pearson test for normality, the data from all 
parameters were not normally distributed except for the percentage of motile 
spermatozoa (P = 0.177).  The data for the parameters in this study shows high 
standard deviation, which is a common finding in biological data (Table 5). 
 
3.2 Semen Parameters 
The sperm count (×10
6
/mL) was negatively correlated with GSH activity in 
spermatozoa (ρ = -0.435; P = 0.0017), and ROS production in the ejaculate  
(ρ = -0.296; P = 0.033).  This parameter also showed a tendency for negative 
correlation with caspase-3/7 activity in sperm (ρ = -0.247; P = 0.0668).  Sperm 
motility was positively correlated with sperm forward progression (ρ = 0.288;  
P = 0.0283). 
 
3.3 Oxidative Status in the Ejaculate and in Spermatozoa 
3.3.1 Peroxidase-positive Leukocytes 
The concentration of peroxidase-positive cells (×10
6
/mL of ejaculate) was positively 
correlated with ROS production in the ejaculate (ρ = 0.378; P = 0.0064), the 
percentage of O2
-•
-positive sperm (ρ = 0.366; P = 0.0098) (Table 6b), and caspase-3/7 
activation in sperm (ρ = 0.527; P < 0.0001).  There was no correlation between the 
concentration of peroxidase-positive cells and semen parameters (Table 6a), the 
percentage of TUNEL-positive sperm (ρ = 0.0195; P = 0.8817), and the percentage of 
Δψm-negative sperm (ρ = 0.0854; P = 0.5121) (Table 6c). 
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Table 5: Summary statistics of all parameters measured in this study. 
 n Mean±SD Median Range P
‡
 
Sperm count (×10
6
/mL) 60 76.8±57.6 80 8-338 <0.0001 
Sperm motility (%) 59 52.5±10.6 50 20-70 0.177 
Forward progression 59 2.53±0.32 2.66 1.33-3.3 0.0049 
Peroxidase-positive cells 
(×10
6
/mL) 
60 0.52±1.28 0.14 0.02-8.9 <0.0001 
ROS production in the 
ejaculate† 
53 10.6±41.7 0.43 -0.5-248 <0.0001 
H2O2-positive sperm 
(Amplex) (%) 
59 21.7±13.9 17.6 2-72 <0.0001 
H2O2-positive sperm (DCF) 
(%) 
60 23.5±13.7 20.4 5.4-89.4 <0.0001 
O2
-•
-positive sperm (DHE) 
(%) 
60 25.9±15.8 21.0 4.1-76.9 0.003 
GSH activity in sperm† 53 73.2±182 18.2 -21-1187 <0.0001 
Δψm-negative sperm (%) 60 25.2-20.1 16.8 4.5-83.9 <0.0001 
Caspase
a
 activation in 
sperm† 
58 247±353 133.8 44-1842 <0.0001 
TUNEL-positive sperm (%) 59 10.3±6.6 9.2 2.3-37.1 <0.0001 
‡ 
P-value for D’Agostino-Pearson test for normality; SD: standard deviation;  
ROS: reactive oxygen species; † ×104 RLU/20×106 sperm; Amplex: Amplex 
UltraRed™; DCF: 2,7-dihydrofluorescein diacetate; a caspase-3/7; GSH: reduced 
glutathione. 
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Table 6a: Relationship between the concentration of peroxidase-positive cells and 
semen parameters. 
 n ρ P-value 
Sperm count (×10
6
/mL) 60 0.0165 0.8989 
Sperm motility 59 0.148 0.2608 
Forward progression 59 0.0043 0.9738 
 
 
Table 6b: Relationship between the concentration of peroxidase-positive cells and 
oxidative status. 
 n ρ P-value 
ROS production in the ejaculate† 53 0.378 0.0064 
H2O2-positive sperm (Amplex) (%) 59 0.210 0.1092 
H2O2-positive sperm (DCF) (%) 60 0.085 0.5162 
O2
-•
-positive sperm (DHE) (%) 60 0.336 0.0098 
GSH activity in sperm† 53 0.211 0.1275 
† ×104 RLU/20×106 sperm. 
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Table 6c: Relationship between the concentration of peroxidase-positive cells and 
sperm apoptotic markers. 
 n ρ P-value 
Δψm-negative sperm (%) 60 0.0854 0.5121 
Caspase
a
 activation in sperm† 58 0.527 <0.0001 
TUNEL-positive sperm (%) 59 0.0195 0.8817 
a
 caspase-3/7; † ×104 RLU/20×106 sperm. 
 
Three cut-off values for leukocyte count in the ejaculate were used to evaluate the 
relationship between the peroxidase-positive cells and other parameters under 
investigation.  These cutoff values (×10
6/mL) were ≥0.25, ≥0.5, and ≥1.0 (Tables 7a-
7c).  At the cut-off value of ≥0.25×106/mL, the concentration of peroxidase-positive 
cells had strong positive correlations with GSH activity in sperm (ρ = 0.718;  
P = 0.0072), the percentage of Δψm-negative sperm (ρ = 0.465; P = 0.0427),  
caspase-3/7 activation in sperm (ρ = 0.794; P = 0.0008), and the percentage of 
TUNEL-negative sperm (ρ = 0.563; P = 0.017).  At the cut-off value of ≥0.5×106/mL, 
peroxidase-positive cell count was positively correlated with ROS production in the 
ejaculate (ρ = 0.817; P = 0.0209) and caspase-3/7 activation in sperm (ρ = 0.729;  
P = 0.0157).  At ≥1.0×106 leukocytes/mL of ejaculate, the concentration of 
peroxidase-positive cells was positively correlated with sperm forward progression  
(ρ = 0.756; P = 0.0455) and ROS production in the ejaculate (ρ = 0.943; P = 0.035). 
As Tables 7a-7c show, the strength of the correlation between peroxidase-positive cell 
concentration and the following parameters had a tendency to increase from lower to 
higher cut-off value; sperm count, sperm motility, forward progression, ROS 
production in the ejaculate, and the percentage of O2
-•
-positive sperm.  Conversely, 
the strength of the correlation decreased from lower cut-off value to higher with other 
parameters (the percentage of H2O2-positive sperm, GSH activity in sperm, the 
percentage of Δψm-negative sperm, caspase-3/7 activation in sperm, and the 
percentage of TUNEL-positive sperm). 
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Table 7a: Relationship between the concentration of peroxidase-positive cells at 
different cut-off values with semen parameters. 
 ≥0.25×106/mL ≥0.5×106/mL ≥1.0×106/mL 
n ρ P n ρ P n ρ P 
Sperm count‡ 20 -0.097 0.6739 12 -0.204 0.4989 8 -0.530 0.1607 
Sperm motility 20 -0.114 0.6196 12 0.107 0.7231 8 0.396 0.2949 
Forward 
progression 
20 0.072 0.7539 12 0.302 0.3173 8 0.756 0.046 
‡ ×106/mL of semen. 
 
Table 7b: Relationship between the concentration of peroxidase-positive cells at 
different cut-off values with oxidative status. 
 ≥0.25×106/mL ≥0.5×106/mL ≥1.0×106/mL 
n ρ P n ρ P n ρ P 
ROS production in 
the ejaculate† 
20 0.234 0.3077 9 0.817 0.021 6 0.943 0.035 
H2O2-positive 
sperm (A) (%) 
20 0.374 0.1031 12 0.263 0.3836 8 0.310 0.4128 
H2O2-positive 
sperm (D) (%) 
20 0.234 0.3077 12 -0.01 0.7538 8 -0.05 0.9068 
O2
-•
-positive 
sperm (DHE) (%) 
20 0.072 0.7539 12 0.302 0.3173 8 0.405 0.2842 
GSH activity in 
sperm† 
15 0.718 0.008 9 0.483 0.1716 6 0.314 0.4822 
† ×104 RLU/20×106 sperm; A: Amplex UltraRed; D: 2,7-dihydrofluorescein diacetate. 
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Table 7c: Relationship between the concentration of peroxidase-positive cells at 
different cut-off values with sperm apoptotic markers. 
 ≥0.25×106/mL ≥0.5×106/mL ≥1.0×106/mL 
n ρ P n ρ P n ρ P 
Δψm-negative 
sperm (%) 
20 0.465 0.043 12 0.399 0.1854 8 0.214 0.5708 
Caspase activation 
in sperm†‡ 
19 0.794 0.001 12 0.729 0.016 8 0.571 0.1306 
TUNEL-positive 
sperm (%) 
19 0.563 0.017 12 0.0525 0.8617 8 0.238 0.5287 
† ×104 RLU/20×106 sperm; ‡ caspase-3/7. 
Furthermore, patients were grouped according to cut-off values for seminal 
leukocytes, and comparisons were made using the Mann-Whitney test between the 
following groups: ≥0.25×106 and <0.25×106 leukocytes/mL of semen; ≥0.5×106 and 
<0.5×10
6/mL, and ≥1×106 and <1×106 leukocytes/mL of semen for the different 
parameters.  For the comparison between the subgroups ≥0.25×106 and <0.25×106 
leukocytes/mL, there were significant differences for peroxidase-positive cell 
concentration (P < 0.0001), ROS production in the ejaculate (P = 0.0188), the 
percentage of O2
-•
-positive sperm (P = 0.023), and caspase-3/7 activation in sperm  
(P = 0.0004).  The Mann-Whitney test between the ≥0.5×106 and <0.5×106/mL 
groups revealed significant differences for peroxidase-positive cells (P < 0.0001), 
ROS production in the ejaculate (P = 0.0004), the percentage of O2
-•
-positive sperm  
(P = 0.0306), GSH activity in sperm (P = 0.0086), caspase-3/7 activation in sperm  
(P = 0.0001), and the percentage of TUNEL-positive sperm (P = 0.0195).  There was 
significance difference between ≥1×106 and <1×106 leukocytes/mL groups for 
peroxidase-positive cells (P < 0.0001), ROS production in the ejaculate (P = 0.0004), 
the percentage of O2
-•
-positive sperm (P = 0.0168), GSH activity in sperm  
(P = 0.0083), and caspase-3/7 activation in sperm (P = 0.0002).  Table 7d shows the 
Mann-Whitney test for differences between the above groups. 
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Table 7d: Mann-Whitney test for differences between the medians of the subgroups according to peroxidase-positive cell concentration  
(×10
6
 leukocytes/mL of semen) for the parameters. 
 Comparison Comparison Comparison 
≥0.25 <0.25  ≥0.5 <0.5  ≥1.0 <1.0  
X±SD X±SD  P X±SD X±SD  P X±SD X±SD  P 
Sperm count (×10
6
/mL) 25.8±18.3 73.7±57.1 0.7301 86.5±62.7 74.4±56.7 0.6309 90.8±69.3 74.6±56.0 0.6170 
Sperm motility (%) 55.5±9.4 51.0±11.0 0.2146 54.2±7.9 52.1±11.2 0.6311 53.8±9.2 52.4±10.9 0.8500 
Forward progression 2.5±0.4 2.5±0.3 0.3327 2.6±0.3 2.5±0.3 0.2960 2.5±0.4 2.5±0.3 0.3300 
ROS production† 346±747 11.1±19.6 0.0188 573±911 10.2±18.5 0.0004 771±1074 20.9±76.6 0.0004 
H2O2-positive cells (A) (%) 25.8±18.3 19.5±10.8 0.3247 31.2±21.0 19.2±10.5 0.0919 36.0±23.9 19.4±10.4 0.0924 
H2O2-positive cells (D) (%) 25.8±18.8 22.4±10.4 0.8754 30.2±21.6 21.9±10.6 0.3183 32.1±26.3 22.2±10.5 0.6093 
O2
-•
-positive sperm (E) (%) 33.6±19.1 22.0±12.5 0.0230 36.6±20.5 23.2±13.4 0.0306 41.0±21.8 23.5±13.5 0.0168 
GSH activity in sperm† 1588±3064 393±821 0.1284 2547±3714 361±773 0.0086 3391±4367 393±789 0.0083 
Δψm-negative sperm (%) 28.1±23.3 23.7±18.5 0.7717 35.6±26.8 22.6±17.5 0.1251 39.0±30.1 23.1±17.6 0.0984 
Caspase
a
 activity in sperm† 4758±5400 1352±970 0.0004 6593±6106 1392±958 0.0001 18421±6608 1488±1061 0.0002 
TUNEL-positive sperm (%) 11.3±8.6 9.8±5.5 0.7518 14.9±8.9 9.1±5.4 0.0195 14.7±10.7 9.6±5.5 0.1597 
‡ ×106 cells/mL of semen; † ROS production in the ejaculate ×104 RLU/20×106 sperm; a caspase-3/7; A: Amplex UltraRed; D: DCF; E: DHE. 
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3.3.2 ROS production in the Ejaculate 
ROS production in the ejaculate was positively correlated with the concentration of 
peroxidase-positive cells (ρ = 0.378; P = 0.0064), GSH activity in sperm (ρ = 0.577;  
P < 0.0001), caspase-3/7 activation in sperm (ρ = 0.487; P = 0.0005), and the 
percentage of TUNEL-positive sperm (ρ = 0.331; P = 0.0171).  In addition, ROS 
production in the ejaculate was negatively correlated with sperm count (ρ = -0.296;  
P = 0.033).  Tables 8a to 8c demonstrate the relationship between ROS production in 
the ejaculate and other parameters. 
 
Table 8a: Relationship between ROS production in the ejaculate and semen 
parameters. 
 n ρ P-value 
Sperm count (×10
6
/mL) 53 -0.296 0.033 
Sperm motility 52 0.0264 0.8502 
Forward progression 52 0.0846 0.5458 
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Table 8b: Relationship between ROS production in the ejaculate and oxidative status. 
 n ρ P-value 
Peroxidase-positive cells (×10
6
/mL) 53 0.378 0.0064 
H2O2-positive sperm (Amplex) (%) 52 0.120 0.3899 
H2O2-positive sperm (DCF) (%) 53 0.169 0.2221 
O2
-•
-positive sperm (DHE) (%) 53 -0.011 0.9358 
GSH activity in sperm† 53 0.577 <0.0001 
† ×104 RLU/20×106 sperm 
. 
Table 8c: Relationship between ROS production in the ejaculate and sperm apoptotic 
markers. 
 n ρ P-value 
Δψm-negative sperm (%) 53 0.175 0.2072 
Caspase
a
 activation in sperm† 52 0.487 0.0005 
TUNEL-positive sperm (%) 53 0.331 0.0171 
a
 caspase-3/7; † ×104 RLU/20×106 sperm. 
 
3.3.3 The percentage of H2O2-positive Sperm 
Hydrogen peroxide is potentially the most harmful ROS, particularly to spermatozoa 
of infertile patients, and two methods were used in this study to detect H2O2-positive 
sperm.  Tables 9a to 9b show the relationship between the percentage of  
H2O2-positive sperm as measured by Amplex UltraRed (Amplex) and  
2,7-dihydrofluorescein diacetate (DCF).  The percentage of H2O2-positive sperm as 
measured by the two methods had a weaker positive correlation than expected  
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(ρ = 0.306; P = 0.0199).  The percentage of H2O2-positive sperm (Amplex) was 
positively correlated with the percentage of TUNEL-positive sperm (ρ = 0.274;  
P = 0.0388).  Notably, there was no correlation between the percentage of  
H2O2-positive sperm and sperm motility (Table 9a), or the percentage of O2
-•
-positive 
sperm (Table 9b). 
 
Table 9a: Relationship between the percentage of H2O2-positive sperm and semen 
parameters. 
 Amplex DCF 
n ρ P-value n ρ P-value 
Sperm count (×10
6
/mL) 59 0.0621 0.6360 60 -0.075 0.5658 
Sperm motility 58 -0.169 0.2050 59 -0.033 0.7994 
Forward progression 58 -0.044 0.7413 59 -0.162 0.2161 
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Table 9b: Relationship between the percentage of H2O2-positive sperm and oxidative 
status. 
 Amplex DCF 
n ρ P-value n ρ P-value 
Peroxidase-positive cells 
(×10
6
/mL) 
58 0.210 0.1092 60 0.0845 0.5162 
ROS production in the ejaculate† 52 0.120 0.3899 53 0.169 0.2221 
H2O2-positive sperm (Amplex) 
(%) 
   59 0.306 0.0199 
H2O2-positive sperm (DCF) (%) 59 0.306 0.0199    
O2
-•
-positive sperm (DHE) (%) 59 0.201 0.1322 60 0.0273 0.8340 
GSH activity in sperm† 52 0.220 0.1168 53 0.198 0.1527 
† ×104 RLU/20×106 sperm. 
 
Table 9c: Relationship between the percentage of H2O2-positive sperm and sperm 
apoptotic markers. 
 Amplex DCF 
n ρ P-value n ρ P-value 
Δψm-negative sperm (%) 59 0.0562 0.6685 60 0.203 0.1198 
Caspase
a
 activation in sperm† 57 0.201 0.1322 58 0.218 0.100 
TUNEL-positive sperm (%) 58 0.274 0.039 59 0.146 0.2649 
 
 
 
 
 
46 
 
Despite the significant correlation, the Wilcoxon test (Figure 12) revealed no 
significant difference between the medians of the two methods employed to determine 
the percentage of H2O2-positive sperm (p = 0.1891).  Furthermore, Bland and Altman 
(Figure 13) and Mountain plots (Figure 14) revealed no significant graphical 
differences between the Amplex and DCF methods. 
 
 
Figure 12 Comparison of the two fluorescence techniques for measuring H2O2 in 
sperm; Amplex UltraRed™ and HRP (Amplex UltraRed, n = 59) and  
2,7-dihydrofluorescein diacetate (H2DCFDA, n = 59).  The Wilcoxon test for paired 
samples revealed no significant differences between the two techniques (P = 0.1891). 
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Figure 13 Bland and Altman plot showing the comparison of the two 
fluorescence methods for measuring H2O2 in spermatozoa.  The differences between 
the two methods are sufficiently centred around zero to conclude that the methods 
have satisfactory agreement. A triangular shape of the distribution is visible.  This 
means that the variation of the data depends on the magnitude of the measurement 
Concordance correlation coefficient was 0.5088 (Pearson ρ = 0.5747; Bias correlation 
factor Cb = 0.9886). 
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Figure 14 Mountain plot showing the comparison of the Amplex and DCF 
fluorescence methods used to detect H2O2 in sperm.  The peak of the graph is close to 
zero, revealing that there is no significant difference between the two methods. 
 
3.3.4 The percentage of O2
-•
-positive Sperm 
The percentage of O2
-•
-positive sperm was positively correlated with the concentration 
of peroxidase-positive cells (ρ = 0.336; P = 0.0098), the percentage of Δψm-negative 
sperm (ρ = 0.261; P = 0.0446), and caspase-3/7 activity in sperm (ρ = 0.457;  
P < 0.0001).  Despite the association with other sperm apoptotic markers, the 
percentage of O2
-•
-positive sperm did not have a significant correlation with the 
percentage of TUNEL-positive sperm (ρ = 0.205; P = 0.205).  Furthermore, there was 
no significant correlation between the percentage of O2
-•
-positive sperm and the 
percentage of H2O2-positive sperm (Amplex, ρ = 0.220; P = 0.1168; DCF, ρ = 0.198; 
P = 0.1527).  In addition, this parameter had a generally non-significant negative 
correlation with semen parameters.  Tables 10a to 10c show the relationship between 
the percentage of O2
-•
-positive sperm and other parameters. 
 
 
 
 
49 
 
Table 10a: Relationship between the percentage of O2
-•
-positive sperm and semen 
parameters. 
 n ρ P-value 
Sperm count (×10
6
/mL) 60 -0.150 0.2487 
Sperm motility 59 0.005 0.9674 
Forward progression 59 -0.109 0.4054 
 
 
Table 10b: Relationship between the percentage of O2
-•
-positive sperm and oxidative 
status. 
 n ρ P-value 
Peroxidase-positive cells (×10
6
/mL) 60 0.336 0.0098 
ROS production in the ejaculate† 53 -0.011 0.9358 
H2O2-positive sperm (Amplex) (%) 59 0.140 0.2863 
H2O2-positive sperm (DCF) (%) 60 0.027 0.8340 
GSH activity in sperm† 53 0.093 0.5013 
† ×104 RLU/20×106 sperm. 
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Table 10c: Relationship between the percentage of O2
-•
-positive sperm and sperm 
apoptotic markers. 
 n ρ P-value 
Δψm-negative sperm (%) 60 0.261 0.0446 
Caspase
a
 activation in sperm† 58 0.457 <0.0001 
TUNEL-positive sperm (%) 59 0.204 0.1207 
a
 caspase-3/7; † ×104 RLU/20×106 sperm. 
 
3.3.5 GSH activity in sperm 
GSH activity in sperm was positively correlated with ROS production in the ejaculate 
(ρ = 0.577; P < 0.0001), the percentage of Δψm-negative sperm (ρ = 0.385;  
P = 0.0055), and caspase-3/7 activation in sperm (ρ = 0.529; P = 0.0002).  This 
parameter also had a significant negative correlation with the sperm count (ρ = -0.435; 
P = 0.0017).  In general, GSH activity in sperm had a negative correlation with semen 
parameters, a non-significant positive correlation with oxidative status parameters, 
and a significant positive correlation with sperm apoptotic markers (Tables 11a to 
11c). 
 
Table 11a: Relationship between GSH activity in sperm and semen parameters. 
 n ρ P-value 
Sperm count (×10
6
/mL) 53 -0.435 0.0017* 
Sperm motility 52 0.049 0.7287 
Forward progression 52 -0.118 0.3996 
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Table 11b: Relationship between GSH activity in sperm and oxidative status. 
 n ρ P-value 
Peroxidase-positive cells (×10
6
/mL) 53 0.211 0.1275 
ROS production in the ejaculate† 53 0.577 <0.0001 
H2O2-positive sperm (Amplex) (%) 52 0.220 0.1168 
H2O2-positive sperm (DCF) (%) 53 0.198 0.1527 
O2
-•
-positive sperm (DHE) (%) 53 0.0933 0.5013 
† ×104 RLU/20×106 sperm. 
 
Table 11c: Relationship between GSH activity in sperm and sperm apoptotic markers. 
 n ρ P-value 
Δψm-negative sperm (%) 53 0.385 0.0055 
Caspase
a
 activation in sperm† 53 0.529 0.0002 
TUNEL-positive sperm (%) 53 0.205 0.1399 
a
 caspase-3/7; † ×104 RLU/20×106 sperm. 
 
3.4 Sperm Apoptotic Markers 
3.4.1 The Percentage of Δψm-negative Sperm 
Tables 12a to 12c illustrate the relationship between the percentage of Δψm-negative 
sperm and other parameters.  The percentage of Δψm-negative sperm had a weak 
positive correlation with the percentage of O2
-•
-positive sperm (ρ = 0.261; P = 0.0446) 
and a stronger positive correlation with GSH activity in sperm (ρ = 0.385;  
P = 0.0055).  This parameter, even though it is an early marker of apoptosis, did not 
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correlate significantly with either caspase activation in sperm or the percentage of 
TUNEL-positive sperm. 
 
Table 12a: Relationship between the percentage of Δψm-negative sperm and semen 
parameters. 
 n ρ P-value 
Sperm count (×10
6
/mL) 60 -0.150 0.2487 
Sperm motility 59 0.005 0.9674 
Forward progression 59 0.084 0.9493 
 
 
Table 12b: Relationship between the percentage of Δψm-negative sperm and 
oxidative status. 
 n ρ P-value 
Peroxidase-positive cells (×10
6
/mL) 60 0.085 0.5121 
ROS production in the ejaculate† 60 0.175 0.2072 
H2O2-positive sperm (Amplex) (%) 59 0.056 0.6685 
H2O2-positive sperm (DCF) (%) 60 0.203 0.1198 
O2
-•
-positive sperm (DHE) (%) 60 0.261 0.0446 
GSH activity in sperm† 53 0.385 0.0055 
† ×104 RLU/20×106 sperm. 
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Table 12c: Relationship of the percentage of Δψm-negative sperm with apoptotic 
markers. 
 n ρ P-value 
Caspase
a
 activation in sperm† 58 0.205 0.1210 
TUNEL-positive sperm (%) 59 0.204 0.1207 
a
 caspase-3/7; † ×104 RLU/20×106 sperm. 
 
3.4.2 Caspase-3/7 Activation in Sperm 
There was no significant correlation between caspase-3/7 activity in sperm and semen 
parameters (Table 13a).  However, caspase-3/7 activation in sperm had a significant 
positive correlation with the concentration of peroxidase-positive cells (ρ = 0.527;  
P = 0.0001), ROS production in the ejaculate (ρ = 0.487; P = 0.0005), the percentage 
of O2
-•
-positive sperm (ρ = 0.457; P = 0.0006), and GSH activity in sperm (ρ = 0.529; 
P = 0.0005) (Table 13b).  Despite the strong correlation with the oxidative status in 
sperm and in the ejaculate, there was no significant correlation between this parameter 
and either the percentage of Δψm-negative sperm or the percentage of TUNEL-
positive sperm (Table 13c). 
 
Table 13a: Relationship between caspase-3/7 activation in sperm and semen 
parameters. 
 n ρ P-value 
Sperm count (×10
6
/mL) 58 -0.243 0.067 
Sperm motility 58 0.157 0.2345 
Forward progression 58 -0.0996 0.4522 
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Table 13b: Relationship between caspase-3/7 activation and oxidative status. 
 n ρ P-value 
Peroxidase-positive cells (×10
6
/mL) 58 0.527 0.0001 
ROS production in the ejaculate† 52 0.487 0.0005 
H2O2-positive sperm (Amplex) (%) 57 0.201 0.1322 
H2O2-positive sperm (DCF) (%) 58 0.218 0.100 
O2
-•
-positive sperm (DHE) (%) 58 0.457 0.0006 
GSH activity in sperm† 52 0.529 0.0002 
† ×104 RLU/20×106 sperm. 
 
Table 13c: Relationship between caspase-3/7 activation and apoptotic markers. 
 n ρ P-value 
Δψm-negative sperm (%) 57 0.0087 0.9484 
TUNEL-positive sperm (%) 57 0.0087 0.9484 
a
 caspase-3/7; † ×104 RLU/20×106 sperm. 
 
3.4.3 The percentage of TUNEL-positive Sperm 
The percentage of TUNEL-positive sperm was positively correlated with ROS 
production in the ejaculate (ρ = 0.331; P = 0.017), and the percentage of H2O2-
positive sperm (Amplex) (ρ = 0.274; P = 0.039).  The relationship between the 
percentage of TUNEL-positive sperm and the other parameters is depicted in Tables 
14a to 14c. 
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Table 14a: Relationship between the percentage of TUNEL-positive sperm and 
semen parameters. 
 n ρ P-value 
Sperm count (×10
6
/mL) 59 -0.133 0.3098 
Sperm motility 58 -0.057 0.6689 
Forward progression 58 0.160 0.2277 
 
 
Table 14b: Relationship between the percentage of TUNEL-positive sperm and 
oxidative status. 
 n ρ P-value 
Peroxidase-positive cells (×10
6
/mL) 59 0.02 0.8817 
ROS production in the ejaculate† 53 0.205 0.1399 
H2O2-positive sperm (Amplex) (%) 58 0.274 0.039 
H2O2-positive sperm (DCF) (%) 59 0.146 0.2649 
O2
-•
-positive sperm (DHE) (%) 59 -0.034 0.7946 
GSH activity in sperm† 53 0.205 0.1399 
† ×104 RLU/20×106 sperm. 
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Table 14c: Relationship between the percentage of TUNEL-positive sperm and sperm 
apoptotic markers. 
 n ρ P-value 
Δψm-negative sperm (%) 59 0.204 0.1207 
Caspase
a
 activation in sperm† 57 0.0087 0.9484 
a
 caspase-3/7; † ×104 RLU/20×106 sperm. 
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CHAPTER FOUR 
 
DISCUSSION 
 
It is now generally accepted that ROS-mediated damage to human sperm is a 
significant contributing factor in the aetiology of impaired sperm function and male 
infertility (Henkel et al., 2003b; Moustafa et al., 2004; Nallela et al., 2005), and 
extensive studies have been conducted to establish the link between oxidative stress 
and defective sperm function by measuring; ROS production by sperm and by 
contaminating leukocytes in the ejaculate (Henkel et al., 2003a); sperm DNA damage 
and its effect on fertilizing potential of the male germ cell (Sun et al., 1997; Alvarez et 
al., 2002; Erenpreiss et al., 2002; Henkel et al., 2003b); lipid peroxidation (Aitken et 
al., 2007; Cosci et al., 2008); and seminal antioxidant capacity (Pasqualotto et al., 
2000; Sharma et al., 2001).  Furthermore, ROS have been recently implicated as 
possible mediators of apoptosis in human spermatozoa (Ramos and Wetzels, 2001; 
Moustafa et al., 2004).  However, data on the effect of male genital tract infection, as 
a significant cause of oxidative stress in the male reproductive tract, on the function of 
spermatozoa and the integrity of the sperm genome is scant. 
Hence, in this study, selected biological assays were performed in order to investigate 
the relationship between male genital tract infection, the oxidative status in 
spermatozoa and the ejaculate, and markers of apoptosis in the male gamete. 
 
4.1 Conventional Semen Parameters 
The influence of ROS on the quality of semen is underpinned by lipid peroxidation 
(Aitken et al., 1993), the induction of which results in loss of sperm plasma 
membrane fluidity (Whittington et al., 1999), decreased axonemal protein 
phosphorylation (de Lamirande and Gagnon, 1992), which leads to impaired sperm 
motility (Agarwal et al., 2003).  Furthermore, the prolonged exposure of the 
seminiferous epithelium to high levels of ROS – produced by either immature sperm 
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or activated leukocytes – damages these tubules and contributes to testicular atrophy, 
reduction of gamete production, and low sperm count (Aziz et al., 2004). 
In this study, sperm count was negatively correlated with ROS in the ejaculate  
(ρ = ­0.296; P = 0.033), and with sperm GSH activity (ρ = ­0.435; P = 0.0017).  This 
inverse relationship between sperm count and ROS in the ejaculate was demonstrated 
in previous studies (Ochsendorf et al., 1994; Henkel and Schill, 1998; Henkel et al., 
2005).  These results confirm that excessive ROS impairs, not only sperm function, 
but also sperm production, depending on the site of ROS production.  The negative 
correlation of sperm count with GSH activity is sperm indicates that reduced 
glutathione may be more active in sperm from men with poor semen parameters. 
 
4.2 Oxidative Status in the Ejaculate and Sperm 
4.2.1 Peroxidase-positive Leukocytes 
The biological role of leukocytes in the ejaculate is subject to on-going controversy 
despite the high incidence of these white blood cells among infertile men (WHO, 
1999; Zorn et al., 2000; Henkel et al., 2007).  In the male reproductive tract, increased 
numbers of seminal leukocytes may result from disturbed spermatogenesis (Wolff et 
al., 1990; Thomas et al., 1997), the harmful influence of environmental factors such as 
smoking (Close et al., 1990), and atypical sexual behavior or prolonged sexual 
abstinence (Blackwell and Zaneveld, 1992; Anderson, 1995).  However, the most 
common reason for infiltration of leukocytes into the ejaculate is genitourinary 
infection/inflammation (Fraczek and Kurpisz, 2007). 
Although the role of seminal leukocytes is in question, it is without doubt that 
leukocytes are the main source of ROS in the ejaculate (Plante et al., 1994).  Not 
surprisingly, this study revealed that the concentration of peroxidase-positive cells 
was positively correlated with ROS in the ejaculate (ρ = 0.378; P = 0.0064).  
Furthermore, peroxidase-positive cells were also positively correlated with the 
percentage of O2
-•
-positive sperm (ρ = 0.336; P = 0.0098) as determined using 
dihydroethidium.  Previously, other studies have demonstrated a similar association 
between seminal leukocytes and ROS production in sperm (Saleh et al., 2002b; 
Henkel et al., 2003a; 2005). 
 
 
 
 
59 
 
The present study also demonstrated a strong positive correlation between the number 
of peroxidase-positive cells and caspase-3/7 activity in the spermatozoa (ρ = 0.527;  
P < 0.0001).  Active caspase-3 in human sperm was reported by Weng et al. (2002) 
but this was not correlated to the number of leukocytes.  As effector caspases, 
caspase-3 and -7 play a central role in apoptosis and, considering that seminal 
leukocytes are associated with excessive ROS production, it is conceivable that ROS 
derived from leukocytes may induce apoptosis in sperm by triggering caspase 
activation.  Indeed, a positive correlation between ROS production in the ejaculate 
and caspase-3 and -9 has been demonstrated (Wang et al., 2003). 
Interestingly, in this study there was no correlation between the number of 
peroxidase-positive cells and the percentage of TUNEL-positive spermatozoa  
(ρ = 0.0195; P = 0.8817).  DNA fragmentation in spermatozoa may be caused by 
internal influences like apoptosis or ROS production in the sperm (Henkel et al., 
2003b), or external inducers like activated leukocytes (Erenpreiss et al., 2002).  
However, ROS production in the ejaculate by leukocytes seems to have a lesser direct 
influence on sperm DNA fragmentation (Henkel et al., 2003b).  Nevertheless, since 
even low levels of ROS can cause DNA damage in spermatozoa, the potential of 
leukocyte-derived oxidative stress to damage the male genome should not be ruled out 
or underestimated.  Seminal leukocytes, activated by stimuli such as inflammation or 
pathogens, respond with an oxidative burst characterized by the production of high 
amounts of oxidants which include hydrogen peroxide (Aitken et al., 1994) and this 
uncharged oxygen derivative can easily permeate plasma membranes and damage 
sperm DNA. 
Some reports indicate that the presence of leukocytes in the ejaculate has no adverse 
influence on semen quality or fertilization potential of spermatozoa (el-Demiry et al., 
1986; Tomlinson et al, 1992; Tomlinson et al., 1993), and some studies even suggest 
positive roles for these cells in the removal of dead or defective sperm from the male 
reproductive tract (Tomlinson et al., 1992; Ricci et al., 2002).  However, most studies 
demonstrate the relationship between the increased number of leukocytes in semen 
and the deterioration of semen parameters (Wolff et al., 1990; Yanushpolsky et al., 
1996) or fertilizing ability of sperm (Vogelpoel et al., 1991, Krausz et al., 1994; 
Sukcharoen et al., 1995), mainly by reducing sperm motility and damaging the 
potential for sperm to penetrate the oocyte (Maruyama et al., 1985; Kovalski et al., 
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1992).  Decreased sperm fertilizing ability may then be an early result of excessive 
ROS production by leukocytes, and prolonged oxidative stress in the male 
reproductive tract may result in impaired spermatogenesis and damaged sperm DNA 
(Fraczek and Kurpisz, 2007). 
 
4.2.2 Cutoff Values for Leukocytospermia 
According to the World Health Organization (WHO, 1999), a condition in which the 
number of leukocytes exceeds 1×10
6
/mL of ejaculate is defined as leukocytospermia, 
and this is considered to be the threshold value above which sperm morphology and 
function are impaired (Menkveld and Kruger, 1998).  However, this value is empirical 
and recent reports suggest that at much lower cut-off values the number of leukocytes 
in the ejaculate is significantly correlated with sperm dysfunction (Henkel and Schill, 
1998; Menkveld and Kruger, 1998; Saleh et al., 2001; Punab et al., 2003; Henkel et 
al., 2005).  Data from the current study showed that at the cut-off value of ≥0.25×106 
leukocytes/mL of semen there was a strongly significant correlation between the 
number of leukocytes in the ejaculate and caspase-3/7 activation in sperm, GSH 
activity in sperm, ROS in the ejaculate, the percentage of sperm with disrupted 
mitochondrial membrane potential (Δψm), and the percentage of TUNEL-positive 
sperm (Tables 7a-7c).  Thus, this study confirms that even in non-leukocytospermic 
patients, oxidative stress can occur which can trigger apoptosis, caspase-3/7 
activation, and induce sperm DNA fragmentation. 
Plante et al. (1994) demonstrated that seminal leukocyte counts of 5×10
6
/mL of 
ejaculate did not impair sperm motility unless the leukocytes were activated.  On the 
other hand, Aitken et al. (1995) reported that leukocytes were harmful to Percoll-
separated sperm at counts of greater than 0.2×10
6
/mL of semen.  This highlights two 
points regarding leukocytes in the ejaculate: firstly, it is not only the leukocyte 
concentration in semen but rather the degree of their activation that determines the 
final effect of oxidative stress on spermatozoa; secondly, that seminal plasma affords 
massive antioxidant protection to spermatozoa.  These factors are important during 
assisted reproduction when spermatozoa are separated from seminal plasma but 
remain proximal to leukocytes in antioxidant-depleted media.  Therefore, sperm 
separation methods should not only include the removal of leukocytes from seminal 
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fluid (Henkel et al., 2005), but also the addition of the antioxidants to sperm 
separation media (Baker et al., 1996). 
 
4.2.3 ROS production in the Ejaculate and in Spermatozoa 
In this study, ROS production in the ejaculate was correlated positively with the 
number of peroxidase-positive cells (ρ = 0.378; P = 0.0064), sperm GSH activity  
(ρ = 0.577; P < 0.0001), caspase-3/7 activity in sperm (ρ = 0.487; P = 0.0005), and the 
percentage of TUNEL-positive sperm (ρ = 0.331; P = 0.0171).  These findings 
confirm previous reports that ROS production in the ejaculate, mostly a consequence 
of activated leukocytes (Aitken et al., 1994), is a possible inducer of apoptosis in 
human sperm; a process in which DNA fragmentation is a hallmark (Wang et al., 
2003). 
Reactive oxygen species play a significant role in the pathophysiology of sperm 
dysfunction (Aitken, 1999; Agarwal et al., 2003) and seminal oxidative stress status 
could be an important diagnostic and prognostic tool in infertility treatment.  Levels 
of ROS production in the ejaculate can be measured by a chemiluminescence assay 
using luminol (5-amino-2,5-dihydro-1,4-phthalazinedione) and a luminometer 
(Shekarriz et al., 1995).  ROS production in the ejaculate is reported to be higher in 
infertile men than in their fertile counterparts (Allamaneni et al., 2005; Nallella et al., 
2005; Athayde et al., 2007; Das et al., 2008) and, not surprisingly, the highest ROS 
production was found in infertile leukocytospermic patients (Allamaneni et al., 2005; 
Athayde et al., 2007). 
Although no receiver operated characteristic (ROC) analysis was performed to 
determine the threshold values for oxidative stress in this study, other authors have 
suggested seminal ROS cut-off values.  Allamaneni et al. (2005) described all seminal 
ROS levels of 18.5×10
4
 RLU per 20×10
6
 sperm as the optimal cut-off value for 
oxidative stress, while other studies reported a optimal cut-off of 10×10
4
 RLU per 
20×10
6
 sperm for washed semen (Shekarriz et al., 1995; Athayde et al., 2007) and 
51.5×10
4
 RLU per 20×10
6
 sperm for semen with leukocytes (Athayde et al., 2007).  
Undoubtedly, the accurate assessment of ROS production levels in the ejaculate may 
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augment the diagnosis of infertility in cases where oxidative stress plays a major role 
and, to this regard, a consensus on normal levels of seminal ROS is essential. 
In order to detect ROS production from spermatozoa, it is necessary to separate these 
cells from contaminating leukocytes, and this can be readily achieved using magnetic 
beads coated with a monoclonal antibody directed against the common leukocyte 
antigen, CD45 (Aitken et al., 1996).  Previous studies have demonstrated that ROS 
production by the spermatozoa of oligozoospermic patients is greater than that 
generated by spermatozoa of fertile donors (Aitken et al., 1992), and the level of ROS 
generation was strongly correlated with the quality of the original semen sample as 
reflected in the movement characteristics of the spermatozoa and their morphology, as 
well as sperm count (Gil-Guzman et al., 2001; Aziz et al., 2004). 
Immature spermatozoa are well characterized sources of ROS in the ejaculate and a 
negative correlation between ROS production and semen quality has been 
documented (Gil-Guzman et al., 2001; Aziz et al., 2004).  It has been hypothesized 
that abnormal spermatozoa with cytoplasmic retentions are significant generators of 
ROS, since they retain an excess of cytoplasmic enzymes that are involved in glucose 
metabolism such as glucose-6-phosphate dehydrogenase (Aitken, 1999).  Moreover, it 
has been confirmed that, when semen is fractionated by a density gradient method, the 
layer with the highest percentage of immature sperm produces the most ROS  
(Gil-Guzman et al., 2001) and this ROS generation is significantly correlated with the 
extent of DNA damage in mature spermatozoa (Ollero et al., 2001; O’Brien and Zini, 
2005).  Spermatozoa also generate ROS from the mitochondrial electron transport 
chain (ETC) during cellular respiration, with an estimated 2% of consumed oxygen 
being converted into the superoxide anion via this route (Boveris and Chance, 1973; 
Koppers et al., 2008). 
In this study, the percentage of O2
-•
-positive sperm was positively correlated with the 
percentage of sperm with disrupted Δψm (ρ = 0.261; P = 0.0446), and caspase-3/7 
activation in sperm (ρ = 0.457; P < 0.0001).  These parameters are indicative of 
apoptosis in spermatozoa and, since the most likely source of O2
-•
 in sperm is 
mitochondrial oxidative phosphorylation, programmed death of the human male germ 
cell is executed via the mitochondrial (intrinsic) apoptotic pathway. 
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This study revealed that the percentage of H2O2-positive sperm (Amplex) was 
positively correlated with the percentage of TUNEL-positive sperm (ρ = 0.274;  
P = 0.0388).  Although no correlation between sperm O2
-•
 production and the 
generation of H2O2 could be shown here, it is known that O2
-•
 is dismutated to H2O2 
by the enzyme superoxide dismutase.  A possible explanation for the lack of 
correlation, in this study, between the generation of these two reactive oxygen species 
by sperm, is that the membrane-permeating H2O2 was produced by seminal 
leukocytes.  Furthermore, the activity of sperm antioxidants, such as glutathione, may 
also distort the relationship between mitochondria-derived O2
-•
 and H2O2 in 
spermatozoa. 
 
4.2.4 GSH activity in Sperm 
Given the potentially toxic nature of ROS to spermatozoa, it is important that the 
oxidants are rapidly scavenged before they trigger lipid peroxidation or DNA damage.  
One of the most significant antioxidants in the modulation of ROS levels in 
mammalian cells is reduced glutathione (Droge et al., 2002).  Data from the present 
study revealed that the activity of GSH in sperm was positively correlated with ROS 
production in the ejaculate (ρ = 0.577; P < 0.0001), the percentage of sperm with 
disrupted Δψm (ρ = 0.385; P = 0.0055), and caspase-3/7 activation in sperm  
(ρ = 0.529; P = 0.0002).  The association of this antioxidant with both, oxidative 
status and sperm apoptotic markers, points to an up-regulation of glutathione 
metabolism to counter the damaging effects of ROS, a relationship demonstrated in 
previous studies (Lewis et al., 1997; Ebisch et al., 2006).  In addition, glutathione has 
been suggested as a global marker for sperm fertilization capacity (Foresta et al., 
2002).  
Glutathione therapy has been reported to be beneficial in some andrological 
pathologies.  Lenzi et al. (1992) administered glutathione to 11 infertile patients, via 
intramuscular injections, and reported a significant improvement in sperm motility 
pattern.  However, Donnelly et al. (2000) reported no significant effect of glutathione 
on sperm motility and DNA damage in vitro.  Ochsendorf et al. (1998) demonstrated 
that men with oligozoospermia had significantly lower sperm glutathione 
concentration than normozoospermic men.  In contrast, Garrido et al. (2004) reported 
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that there was no significant difference between glutathione concentration in sperm 
from fertile and subfertile patients.  Therefore, there is need for more investigations to 
improve our understanding of the role of glutathione in the function of spermatozoa. 
 
4.3 Apoptotic Markers in Spermatozoa 
Apoptosis is the underlying process for maintaining homeostasis during 
spermatogenesis (Sakkas et al., 2003; Giampietri et al., 2005) and, recently, several 
reports have suggested that the apoptotic process also occurs in mature sperm 
(Oehninger et al., 2003; Lachaud et al., 2004). These studies were based on the 
presence of biochemical markers of apoptosis which include mitochondrial membrane 
potential disruption (Barroso et al., 2006), plasma membrane translocation of 
phosphatidylserine (Kotwicka et al., 2008), the activity of aspartic acid-derived 
cysteine proteases (caspases) (Grunewald et al., 2005), DNA fragmentation (Sakkas et 
al., 2002; Tesarik et al., 2006), and the presence of pro- and anti-apoptotic proteins 
(Paasch et al., 2003). 
In this study, Δψm disruption, caspase-3/7 activation and DNA fragmentation, were 
investigated as suitable markers of apoptosis in spermatozoa: the first parameter as an 
early event of this process, and the latter two as executioner and late event, 
respectively. 
 
4.3.1 Disruption of the MMP (Δψm) 
The sperm mitochondria are an important focus of ROS-induced damage and, since 
intact Δψm is required for mitochondrial ATP production, this damage can result in 
the loss of sperm motility (de Lamirande and Gagnon, 1992).  The disruption of Δψm 
is also a general feature of early stage apoptosis that precedes other manifestations of 
this process such as DNA fragmentation (Kroemer et al., 1997). 
In the present study, the percentage of sperm with Δψm disruption was positively 
correlated with the percentage of O2
-•
-positive sperm (ρ = 0.261; P = 0.0045) and the 
activity of GSH in sperm (ρ = 0.385; P = 0.0055).  This appears to indicate that sperm 
Δψm can be disrupted by excessive O2
-•
 production.  Schulz et al. (2009) reported that 
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incubation of sperm from healthy donors with E. coli can induce significant Δψm 
disruption which was associated with diminished sperm motility and vitality.  This 
demonstrates that ROS generated from outside the spermatozoa, for example, in 
patients with male genital tract infection/inflammation or leukocytospermia, can 
destabilize mitochondrial function and trigger more internal ROS production which 
can lead to apoptosis in spermatozoa.  This is in agreement with reports by several 
authors that externally-derived ROS may act as apoptosis mediators (Armstrong et al., 
1999; Vicari, 1999; Agarwal and Said, 2005; Villegas et al., 2005).  Other studies 
have reported significant correlation between sperm Δψm and sperm motility 
(Marchetti et al., 2002; Wang et al., 2003; Zhang et al., 2008), and caspase-3 activity 
(Said et al., 2004; Angelopoulou et al., 2007), and sperm mitochondrial membrane 
potential has been recommended as a sensitive evaluation for sperm quality 
(Marchetti et al., 2002; 2004). 
The significance of the positive correlation between the percentage of sperm with 
Δψm disruption and sperm GSH activity is not clear.  However, given the association 
of sperm GSH activity with oxidative status in the ejaculate and sperm caspase-3/7 
activity, the correlation with sperm Δψm suggests an increase in GSH activity in the 
response to oxidative stimuli in the sperm or in seminal plasma. 
 
4.3.2 Caspase-3/7 activation in Sperm 
It is now established that the central component of the apoptotic machinery involves 
one or more members of a family of aspartic acid-directed cysteine proteases called 
caspases (Thornberry and Lazebnik, 1998).  The activity of caspases in human 
spermatozoa has been positively correlated with oxidative stress (Wang et al., 2003) 
and DNA fragmentation (Weng et al., 2002) in infertile patients. 
In this study, sperm caspase-3/7 activation was positively correlated with the 
percentage of peroxidase-positive cells (ρ = 0.527; P = 0.0001), ROS production in 
the ejaculate (ρ = 0.487; P = 0.0005), the percentage of O2
-•
-positive sperm  
(ρ = 0.457; P = 0.0006), and GSH activity in sperm (ρ = 0.529; P = 0.0002).  Clearly, 
there is a significant strong relationship between the activity of caspase-3/7 and the 
oxidative status in the ejaculate and in spermatozoa.  Seminal leukocytes are the 
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principal source of ROS in the ejaculate, and they have been linked with oxidative 
stress even in non-leukocytospermic patients (Henkel et al., 2003a).  Therefore, it can 
be hypothesized that these cells can induce apoptosis via the caspase cascade.  Recent 
studies have revealed that activated caspase-3 was localized exclusively to the 
midpiece area of positively-stained sperm (Weng et al., 2002; Almeida et al., 2005; 
Kotwicka et al., 2008), indicating that caspase-dependant apoptosis in sperm may be 
sequestered in a region where mitochondria and cytoplasmic droplets would be 
located.  Significant correlation between caspase-3 activity and DNA fragmentation 
has been reported (Weng et al., 2002) but this association may not be consistent, as 
reflected by the current study.  Some studies have demonstrated that apoptosis may 
not significantly contribute to sperm DNA damage (Moustafa et al., 2004) while 
others have even reported that oxidative stress-induced apoptosis may be caspase-
independent (Grunewald et al., 2005). 
Understanding the mechanism of caspase regulation is intimately linked to the ability 
to manipulate apoptosis for therapeutic gain (Thornberry and Lazebnik, 1998; Brill et 
al., 1999).  Therefore, given the conflicting reports in this and other studies on the 
relationship between caspase activity and sperm function, further investigation is 
indicated. 
 
4.3.3 Sperm DNA Fragmentation 
The success of fertilization and the subsequent development of the embryo in humans 
depend, partly, on the integrity of the sperm DNA (Ahmadi and Ng, 1999).  
Spermatozoa of infertile men exhibit substantially more DNA damage compared to 
sperm of fertile men (Evenson et al., 1999; Irvine et al., 2000), and clinical evidence 
shows that damage to the male genome may adversely affect reproductive outcomes 
(Zini et al., 2001; Duran et al., 2002; Henkel et al., 2004).  However, our 
understanding of the causes of sperm DNA damage remains rudimentary and, of the 
several proposed hypotheses of causes of DNA damage in human spermatozoa, the 
major theories are; poor chromatin packaging, abortive apoptosis, and oxidative 
stress. 
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Poor protamination of sperm DNA during spermatogenesis is clearly a major factor in 
determining the susceptibility of sperm chromatin to damage (Nasr-Esfahani et al., 
2005; Carrell et al., 2006).  This incomplete packaging of sperm chromatin has been 
reported in 5-15% of infertile men (Carrell and Liu, 2001; Oliva, 2006), and it has 
been linked with poor fertilizing potential and DNA fragmentation (Cho et al., 2003; 
Aoki et al., 2006).  Furthermore, protamination of sperm chromatin appears to protect 
sperm DNA from oxidative stress by sequestering transition metals that are capable of 
promoting sperm DNA fragmentation (Liang et al., 1999).  Therefore, this function 
may account for the extensive DNA damage observed in spermatozoa of with 
incomplete protamine-histone transition (Bianchi et al., 1993). 
In addition to poor chromatin packaging, DNA fragmentation in spermatozoa of 
infertile men may involve an incomplete apoptotic pathway that is mediated by the 
cell surface protein; fibroblast associated (Fas) death receptor (Sakkas et al., 1999).  
The induction of apoptosis via the Fas pathway is an important mechanism by which 
Sertoli cells regulate the number and quality of germ cells, particularly under stressful 
conditions (Boekelheide et al., 2000).  Sakkas et al. (1999) proposed that some of the 
spermatozoa with DNA damage exhibited Fas because they had been earmarked for 
elimination, but had escaped apoptosis; hence this process is called ‘abortive 
apoptosis’.  However, despite reports of higher incidence of Fas in sperm of men with 
poor semen parameters (Sakkas et al., 2002), there is no consensus on the percentage 
of Fas-positive sperm in the human ejaculate (Henkel et al., 2004). In addition, Castro 
et al. (2004) found no significant Fas in ejaculated sperm of both normozoospermic 
and non-normozoospermic men, while McVicar et al. (2004) could demonstrate Fas 
in sperm of infertile men only.  Furthermore, the presence of Fas in human ejaculated 
sperm is related to, neither DNA damage as detected by the Comet assay, nor 
fertilization and pregnancy (Henkel et al., 2004; McVicar et al., 2004). 
Alternatively, sperm DNA damage has been associated with high levels of reactive 
oxygen species (Barroso et al., 2000; Irvine et al., 2000).  Sperm DNA fragmentation 
has been correlated with sperm-derived ROS (Henkel et al., 2003b) and this may be 
reflective of an underlying defect of spermatogenesis as it is sperm with cytoplasmic 
retentions that are largely responsible for sperm free radical generation (Gomez et al., 
1996).  Male genital tract infection associated with leukocytospermia has also been 
associated with DNA damage in spermatozoa (Sharma et al., 2001; Alvarez et al., 
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2002; Erenpreiss et al., 2002) although this relationship is not always demonstrated 
(Henkel et al., 2003b).  The negative effects of seminal leukocytes are mediated by 
oxidative stress, of which the stable H2O2 molecule is the most pernicious reactive 
oxygen species, particularly to spermatozoa of infertile men (Hughes et al., 1996). 
In the current study, the percentage of TUNEL-positive sperm was positively 
correlated with ROS production in the ejaculate (ρ = 0.331; P = 0.017) and the 
percentage of H2O2-positive sperm (Amplex UltraRed) (ρ = 0.274; P = 0.039).  Data 
from this study lends some support to the oxidative stress hypothesis of sperm DNA 
damage but the evidence is inconclusive as there is no correlation of sperm DNA 
damage with Δψm, caspase activation or the concentration of seminal leukocytes.  
Some studies have also demonstrated that TUNEL positivity and apoptotic markers 
may not always correlate (Sakkas et al., 2002; Moustafa et al., 2004).  This suggests 
that DNA fragmentation may be independent of classical apoptotic pathways, and that 
ROS may directly damage nuclear DNA in sperm. 
 
4.4 Conclusions and Future Outlook 
This study confirms that leukocytes are the major source of ROS production in the 
ejaculate, and that they may be related to the generation of O2
-•
 in spermatozoa.  
Despite the positive correlation between ROS production in the ejaculate and sperm 
caspase-3/7 activity, the association between seminal oxidative stress and sperm 
apoptotic markers is rather tenuous.  However, there is a relationship between sperm-
derived O2
-•
 and sperm Δψm .  In the light of these links, it would be important to 
investigate further what is going on in sperm mitochondria under the influence 
extrinsic ROS generated by leukocytes in the course of male genital tract 
infection/inflammation. 
In addition, the superoxide anion may have a more prominent contribution to 
apoptosis than previously reported.  The generation of this free radical in somatic cells 
is thought to involve electron leakage from the mitochondrial electron transfer chain 
(ETC) during normal cellular respiration, with an estimated 2% of consumed oxygen 
being converted to O2
-• 
in this manner (Boveris and Chance, 1973).  Normally, this 
ROS production is balanced by the antioxidant store within the cytoplasm and the 
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mitochondrial matrix (Andreyev et al., 2005).  However, excessive mitochondrial 
ROS generation may outstrip the limited antioxidant defences, resulting in oxidative 
stress.  This intrinsic generation of O2
-•
 has been described in human spermatozoa by 
Koppers et al. (2008) and it has been positively correlated with poor motility by the 
same authors. 
Commonly overlooked is the fact that sperm carry two different kinds of DNA; 
nuclear and mitochondrial.  Mitochondria, which are located in the sperm mid-piece, 
are the energy generators of spermatozoa and supply adenosine triphosphate which 
helps propel the sperm towards the oocyte for fertilization.  Mitochondrial DNA 
(mtDNA) encodes for two ribosomal RNAs, 22 transfer RNAs, and 13 polypeptides 
that are essential for mitochondrial respiration and oxidative phosphorylation 
associated with the electron transfer chain.  Current understanding of the role of 
mitochondria in disease is expanding, and it is becoming clear that mitochondrial 
dysfunction may be a significant factor in some cases of male infertility and 
asthenozoospermia (Følgero et al., 1993; Ruiz-Pesini et al., 2000).  In the context of 
sperm function mitochondria are important, not only because they are the powerhouse 
of the germ cell, but because as the site of oxidative phosphorylation they are a major 
source of electron leakage from the ETC (Chance et al., 1979; Giulivi et al., 1995) 
which is a significant contributor to internal ROS production by sperm (Koppers et 
al., 2008).  In addition, mitochondria are involved in the regulation of apoptosis by 
means of the mitochondrial or intrinsic pathway (Gogvadze and Orrenius, 2006), and 
in sperm this process is characterized by the loss of mitochondrial membrane potential 
(Marchetti et al., 2002; Zhang et al., 2008), caspase-3 activity (Weng et al., 2002), and 
nuclear DNA fragmentation (Wang et al., 2003).  Furthermore, mtDNA is located on 
the matrix side of the mitochondrial inner membrane (Antunes et al., 1996) and 
consequently it is vulnerable to oxidative damage by mitochondrial-derived ROS.  
Mitochondrial DNA is more susceptible to oxidation by ROS because, unlike nuclear 
DNA, it lacks protective packaging proteins such as protamines and histones 
(Marchesi and Feng, 2007).  Moreover, mtDNA replicates at a faster rate without 
proper proofreading and only has a basic repair mechanism (Croteau et al., 1999) and 
this makes the genome prone to mutations and deletions in spermatozoa (O’Connell et 
al., 2002).  Since mtDNA is essential to the energy generation role of mitochondria in 
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spermatozoa, it is indispensable for successful fertilization and there is need to gather 
more data on the effects of mtDNA damage on male infertility. 
In conclusion, this study has demonstrated a clear association between the 
concentration of seminal leukocytes and ROS production in the ejaculate and in 
spermatozoa.  Moreover, seminal leukocyte concentration was strongly correlated 
with the effector caspases; -3 and -7.  Therefore, there is a case for a relationship 
between male genital tract infection and sperm oxidative stress, which may lead to 
sperm apoptosis via the mitochondrial pathway. 
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